Umberto Capitanio
#143,722
Most Influential Person Now
Researcher ORCID ID = 0000-0001-9225-1795
Umberto Capitanio's AcademicInfluence.com Rankings
Umberto Capitanioeconomics Degrees
Economics
#3126
World Rank
#3547
Historical Rank
Agricultural Economics
#29
World Rank
#31
Historical Rank
Environmental Economics
#45
World Rank
#45
Historical Rank
Download Badge
Economics
Umberto Capitanio's Degrees
- PhD Economics University of Milan
- Masters Economics University of Milan
- Bachelors Economics University of Milan
Similar Degrees You Can Earn
Why Is Umberto Capitanio Influential?
(Suggest an Edit or Addition)Umberto Capitanio's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Renal Cancer (2016) (685)
- Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. (2012) (592)
- Epidemiology of Renal Cell Carcinoma. (2019) (548)
- Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. (2011) (223)
- Radical versus partial nephrectomy (2009) (220)
- Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. (2015) (196)
- Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. (2009) (187)
- More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. (2015) (184)
- Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. (2011) (182)
- Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies. (2019) (182)
- Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. (2009) (178)
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. (2022) (176)
- Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. (2010) (176)
- When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool. (2010) (159)
- Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. (2010) (155)
- The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? (2009) (154)
- Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. (2010) (153)
- International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy (2010) (147)
- Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. (2009) (147)
- Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. (2008) (144)
- A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population‐based study (2009) (135)
- Benign Prostatic Hyperplasia and Its Aetiologies (2009) (134)
- A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. (2009) (133)
- A population based assessment of perioperative mortality after cystectomy for bladder cancer. (2009) (130)
- Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection. (2012) (129)
- Lymph node dissection in renal cell carcinoma. (2011) (126)
- Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. (2009) (119)
- Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. (2013) (110)
- Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification. (2010) (110)
- Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. (2010) (107)
- Can nomograms be superior to other prediction tools? (2009) (103)
- Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain. (2012) (102)
- Currently used criteria for active surveillance in men with low‐risk prostate cancer (2008) (99)
- Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer. (2020) (99)
- Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men (2008) (96)
- A delay in radical nephroureterectomy can lead to upstaging (2010) (94)
- Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy. (2013) (94)
- Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. (2014) (93)
- The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. (2010) (91)
- Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group). (2018) (91)
- Nerve‐sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery (2013) (89)
- Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. (2012) (89)
- Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. (2010) (87)
- The Learning Curve for Robot-assisted Partial Nephrectomy: Impact of Surgical Experience on Perioperative Outcomes. (2018) (87)
- Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres (2020) (86)
- The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care. (2021) (82)
- Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma. (2018) (79)
- The use of partial nephrectomy in European tertiary care centers. (2009) (78)
- Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma. (2020) (75)
- Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. (2009) (74)
- Stage‐specific effect of nodal metastases on survival in patients with non‐metastatic renal cell carcinoma (2009) (74)
- p53 expression in patients with advanced urothelial cancer of the urinary bladder (2010) (74)
- Mortality at 120 days after prostatic biopsy: A population‐based study of 22,175 men (2008) (73)
- Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. (2009) (72)
- Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. (2009) (72)
- Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study. (2009) (72)
- The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta‐analysis (2018) (69)
- Role of Active Surveillance for Localized Small Renal Masses. (2018) (69)
- Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review. (2019) (68)
- Lymphatic spread of nodal metastases in high‐risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum (2012) (68)
- Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy (2012) (67)
- Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer (2009) (66)
- Extent of lymph node dissection at nephrectomy affects cancer‐specific survival and metastatic progression in specific sub‐categories of patients with renal cell carcinoma (RCC) (2014) (66)
- Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer. (2008) (65)
- Impact of clinical factors, including a point‐of‐care nuclear matrix protein‐22 assay and cytology, on bladder cancer detection (2009) (64)
- A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. (2010) (63)
- Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. (2008) (63)
- Thirty-day mortality after nephrectomy: clinical implications for informed consent. (2009) (63)
- Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. (2019) (63)
- p53 predictive value for pT1-2 N0 disease at radical cystectomy. (2009) (58)
- Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention (2011) (56)
- Preoperative hypogonadism is not an independent predictor of high‐risk disease in patients undergoing radical prostatectomy (2011) (56)
- Conditional survival predictions after nephrectomy for renal cell carcinoma. (2009) (55)
- Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma (2009) (54)
- Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project). (2019) (54)
- Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. (2016) (53)
- How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications (2011) (52)
- Which Patients with Upper Tract Urothelial Carcinoma Can be Safely Treated with Flexible Ureteroscopy with Holmium:YAG Laser Photoablation? Long‐Term Results from a High Volume Institution (2017) (52)
- Testing the most stringent criteria for selection of candidates for active surveillance in patients with low‐risk prostate cancer (2010) (52)
- Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study. (2020) (51)
- A comparative population‐based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma (2010) (50)
- Suture techniques during laparoscopic and robot‐assisted partial nephrectomy: a systematic review and quantitative synthesis of peri‐operative outcomes (2018) (49)
- Cancer‐specific and non‐cancer‐related mortality rates in European patients with T1a and T1b renal cell carcinoma (2009) (46)
- Prediction of sexual function after radical prostatectomy (2009) (45)
- Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. (2008) (45)
- External validation of the updated partin tables in a cohort of French and Italian men. (2009) (45)
- Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi‐Institutional Analysis (2017) (43)
- When to perform lymph node dissection in patients with renal cell carcinoma: a novel approach to the preoperative assessment of risk of lymph node invasion at surgery and of lymph node progression during follow‐up (2013) (43)
- Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors. (2009) (43)
- Preoperative erectile function represents a significant predictor of postoperative urinary continence recovery in patients treated with bilateral nerve sparing radical prostatectomy. (2012) (43)
- End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline. (2016) (43)
- Circulating estradiol, but not testosterone, is a significant predictor of high‐grade prostate cancer in patients undergoing radical prostatectomy (2011) (42)
- What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy? (2011) (42)
- External validation of the updated Partin tables in a cohort of North American men. (2008) (42)
- Prediction of delayed graft function after renal transplantation. (2013) (42)
- Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy (2009) (42)
- The ERUS Curriculum for Robot-assisted Partial Nephrectomy: Structure Definition and Pilot Clinical Validation. (2019) (41)
- Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (2008) (41)
- Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound‐guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy (2012) (41)
- Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? (2011) (41)
- Choosing the best candidates for penile rehabilitation after bilateral nerve-sparing radical prostatectomy. (2012) (40)
- Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. (2011) (40)
- The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme. (2011) (38)
- Independent Validation of a Model Predicting the Need for Packed Red Blood Cell Transfusion at Liver Transplantation (2009) (38)
- A population‐based comparison of survival after nephrectomy vs nonsurgical management for small renal masses (2009) (38)
- Retroperitoneal vs Transperitoneal Robot-assisted Partial Nephrectomy: Comparison in a Multi-institutional Setting. (2018) (37)
- Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma. (2014) (37)
- Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art (2012) (37)
- Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series. (2009) (37)
- Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score‐matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group (2020) (36)
- Summary of the International Conference on Onco-Nephrology: an emerging field in medicine. (2019) (36)
- The rationale and the role of lymph node dissection in renal cell carcinoma (2017) (36)
- Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best. (2008) (35)
- Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy. (2009) (33)
- Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. (2020) (33)
- Predictive models before and after radical prostatectomy (2010) (33)
- Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes. (2018) (33)
- Erectile function outcome after bilateral nerve sparing radical prostatectomy: which patients may be left untreated? (2012) (33)
- The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy (2011) (33)
- The impact of lymph node dissection and positive lymph nodes on cancer‐specific mortality in contemporary pT2‐3 non‐metastatic renal cell carcinoma treated with radical nephrectomy (2018) (33)
- Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease. (2012) (32)
- Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series. (2012) (32)
- Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium. (2017) (32)
- A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma (2009) (31)
- Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass. (2021) (31)
- Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma (2008) (31)
- Random biopsy: when, how many and where to take the cores? (2014) (31)
- Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study. (2019) (31)
- Partin Tables cannot accurately predict the pathological stage at radical prostatectomy. (2009) (30)
- Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy (2013) (29)
- Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer. (2020) (29)
- Follow-up After Treatment for Renal Cell Carcinoma: The Evidence Beyond the Guidelines. (2016) (29)
- A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States. (2009) (28)
- Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival (2016) (28)
- Influence of obesity on tumour volume in patients with prostate cancer (2012) (27)
- Predicting survival of men with recurrent prostate cancer after radical prostatectomy. (2016) (27)
- Age‐adjusted validation of the most stringent criteria for active surveillance in low‐risk prostate cancer patients (2012) (27)
- Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer. (2017) (27)
- Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia. (2018) (27)
- Race affects access to nephrectomy but not survival in renal cell carcinoma (2009) (27)
- Surgical quality, cancer control and functional preservation: introducing a novel Trifecta for robot-assisted partial nephrectomy. (2019) (27)
- Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter. (2016) (26)
- Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma. (2020) (26)
- Systematic Review and Pooled Analysis of the Impact of Renorrhaphy Techniques on Renal Functional Outcome After Partial Nephrectomy. (2019) (26)
- Radical prostatectomy represents an effective treatment in patients with specimen‐confined high pathological Gleason score prostate cancer (2013) (25)
- Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates (2013) (25)
- The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. (2018) (25)
- Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease (2017) (24)
- The Extent of Lymphadenectomy does Affect Cancer Specific Survival in Pathologically Confirmed T4 Renal Cell Carcinoma (2012) (24)
- Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group) (2019) (24)
- A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy (2010) (24)
- Naftopidil for the treatment of benign prostate hyperplasia: a systematic review (2014) (24)
- ‘Trifecta’ outcomes of robot‐assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis (2018) (24)
- Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection. (2009) (24)
- Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy. (2012) (23)
- Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma (2021) (23)
- Techniques and outcomes of minimally-invasive surgery for nonmetastatic renal cell carcinoma with inferior vena cava thrombosis: a systematic review of the literature. (2019) (23)
- Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. (2009) (22)
- External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma (2009) (22)
- On‐clamp versus off‐clamp partial nephrectomy: Propensity score‐matched comparison of long‐term functional outcomes (2019) (22)
- Peyronie's disease and autoimmunity—a real-life clinical study and comprehensive review. (2015) (22)
- Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: Implications for multimodal therapy (2013) (22)
- When should we expect no residual tumor (pT0) once we submit incidental T1a‐b prostate cancers to radical prostatectomy? (2011) (22)
- Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature. (2021) (22)
- National Comprehensive Cancer Network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer. (2012) (22)
- Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infections. (2013) (21)
- Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium. (2017) (21)
- Outcomes of robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter analysis. (2020) (21)
- The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted (2009) (21)
- Survival After Conservative Management Versus External Beam Radiation Therapy in Elderly Patients With Localized Prostate Cancer. (2016) (20)
- Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve‐sparing radical prostatectomy (2013) (20)
- Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. (2019) (20)
- Sexual functioning mirrors overall men's health status, even irrespective of cardiovascular risk factors (2017) (20)
- Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients (2017) (20)
- Systematic Review of the Management of Local Kidney Cancer Relapse. (2018) (20)
- Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project) (2019) (20)
- The extent of tumour fat invasion affects survival in patients with renal cell carcinoma and venous tumour thrombosis (2011) (20)
- Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study. (2016) (19)
- mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma. (2018) (19)
- Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables. (2009) (19)
- Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study. (2019) (19)
- Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma. (2022) (19)
- Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma) (2009) (19)
- 2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma. (2021) (19)
- There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. Implications for focal therapies (2012) (19)
- Upstaging to pT3a in Patients Undergoing Partial or Radical Nephrectomy for cT1 Renal Tumors: A Systematic Review and Meta-analysis of Outcomes and Predictive Factors. (2020) (18)
- Long-term recovery of normal sexual function in testicular cancer survivors (2015) (18)
- Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis (2013) (18)
- European temporal trends in the use of lymph node dissection in patients with renal cancer. (2017) (18)
- The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. (2020) (18)
- The Impact of Surgical Strategy in Robot-assisted Partial Nephrectomy: Is It Beneficial to Treat Anterior Tumours with Transperitoneal Access and Posterior Tumours with Retroperitoneal Access? (2019) (18)
- Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion (2016) (18)
- Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project). (2020) (18)
- Current Status of Focal Cryoablation for Small Renal Masses. (2016) (18)
- Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort. (2009) (18)
- Awareness and knowledge of human papillomavirus-related diseases are still dramatically insufficient in the era of high-coverage vaccination programs (2015) (17)
- Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) (2018) (17)
- Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality? (2016) (17)
- GENDER IS AN IMPORTANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENT WITH TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY (2009) (17)
- Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis. (2020) (17)
- Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project). (2020) (17)
- Reply to Michael Staehler's Letter to the Editor re: Pierre I Karakiewicz, Nazareno Suardi, Claudio Jeldres, et al. Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi. Eur Urol 2008;53:845-848 (2008) (17)
- Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old: Analysis of the REnal SURGery in Elderly (RESURGE) Group. (2020) (17)
- Does histologic subtype affect oncologic outcomes after nephron-sparing surgery? (2009) (17)
- Preoperative frailty predicts adverse short‐term postoperative outcomes in patients treated with radical nephroureterectomy (2020) (16)
- Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy (2017) (16)
- The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer. (2013) (16)
- Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy. (2017) (16)
- Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. (2022) (16)
- Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses. (2020) (16)
- Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review. (2020) (16)
- Renal Tumor Biopsy: More Dogma Belied. (2015) (15)
- Population‐based assessment of cancer‐specific mortality after local tumour ablation or observation for kidney cancer: a competing risks analysis (2016) (15)
- Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification. (2013) (15)
- Conversion of Robot-assisted Partial Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study. (2017) (15)
- Robot-assisted partial nephrectomy: 7-year outcomes (2021) (15)
- Erratum: Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection (BJU International (2009) 103 (1368-1374)) (2010) (15)
- Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project) (2020) (15)
- Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy (2011) (15)
- Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. (2009) (15)
- 1851 RENAL AND CARDIOVASCULAR MORBIDITY AFTER PARTIAL OR RADICAL NEPHRECTOMY IN PATIENTS WITH KIDNEY TUMORS UP TO 7 CENTIMETERS: IMPLICATIONS ON OVERALL MORTALITY (2013) (14)
- Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool (2012) (14)
- Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue? (2020) (14)
- Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology (2018) (14)
- Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most? (2016) (14)
- Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis (2020) (14)
- A Multirobots Teleoperated Platform for Artificial Intelligence Training Data Collection in Minimally Invasive Surgery (2019) (14)
- Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. (2008) (14)
- Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). (2018) (14)
- Prediction of Competing Mortality for Decision-making Between Surgery or Observation in Elderly Patients With T1 Kidney Cancer. (2017) (14)
- Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines. (2020) (14)
- Robot-assisted partial nephrectomy: 7-year outcomes. (2020) (14)
- Predictors of Cancer‐specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence (2018) (14)
- Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (2019) (14)
- High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer (2008) (14)
- Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States. (2019) (13)
- Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: an International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria. (2019) (13)
- How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications. (2012) (13)
- Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. (2018) (13)
- A nomogram predicting metastatic progression after radical prostatectomy (2008) (13)
- On-clamp versus off-clamp partial nephrectomy: Propensity score matched comparison of long term functional outcomes (2017) (13)
- Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study (2018) (13)
- A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02. (2021) (13)
- Comprehensive long-term assessment of outcomes following robot-assisted partial nephrectomy for renal cell carcinoma: the ROMe's achievement and its predicting nomogram. (2020) (13)
- Optimizing postoperative sexual function after radical prostatectomy (2012) (13)
- Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors (2019) (12)
- When to perform preoperative chest computed tomography for renal cancer staging (2017) (12)
- Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma (2020) (12)
- Repeat Prostate Biopsy: Rationale, Indications, and Strategies. (2015) (12)
- Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab. (2021) (12)
- Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases. (2017) (12)
- Contemporary management of patients with T1a and T1b prostate cancer (2011) (12)
- Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration. (2020) (12)
- Do We Truly Care About the Functional Outcomes for Renal Cancer Patients? Multidisciplinarity Is Still Far Away. (2019) (12)
- Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer (2017) (12)
- Adjuvant Therapies in Nonmetastatic Renal‐Cell Carcinoma: A Review of the Literature (2018) (12)
- Growth and renal function dynamics of renal oncocytomas in patients on active surveillance (2021) (12)
- Repeated biopsy in the detection of prostate cancer: when and how many cores. (2014) (11)
- Sex hormone‐binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy (2011) (11)
- Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter Series. (2020) (11)
- Virtual Reality Validation of the ERUS Simulation-based Training Programmes: Results from a High-volume Training Centre for Robot-assisted Surgery. (2019) (11)
- Enhancing Surgical Process Modeling for Artificial Intelligence development in robotics: the SARAS case study for Minimally Invasive Procedures (2019) (11)
- Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy (2019) (11)
- The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma (2018) (11)
- The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. (2014) (11)
- Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation. (2021) (11)
- Predicting intra‐operative and postoperative consequential events using machine‐learning techniques in patients undergoing robot‐assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database study (2020) (10)
- Should partial nephrectomy be considered “elective” in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy (2019) (10)
- Lymph node dissection for renal cell carcinoma: what are we missing? (2016) (10)
- The importance of interaction between urologists and pathologists in incidental prostate cancer management. (2011) (10)
- Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy? (2017) (10)
- Risk Based Surveillance after Surgical Treatment of Renal Cell Carcinoma (2018) (10)
- Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening. (2008) (10)
- Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses. (2021) (10)
- Circulating sex steroids and prostate cancer: introducing the time-dependency theory (2013) (9)
- Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review. (2021) (9)
- Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset. (2020) (9)
- Technical and Functional Validation of a Teleoperated Multirobots Platform for Minimally Invasive Surgery (2020) (9)
- Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy (2012) (9)
- The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy. (2019) (9)
- LYMPHOVASCULAR INVASION IS A POWERFUL PREDICTOR OF CLINICAL OUTCOMES IN NODE-NEGATIVE RADICAL CYSTECTOMY PATIENTS: AN INTERNATIONAL EXTERNAL VALIDATION STUDY (2009) (9)
- Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma (2019) (9)
- Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma. (2020) (9)
- Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer‐specific survival in a matched case‐control study (2009) (9)
- The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer. (2020) (9)
- Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma (2022) (9)
- The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting. (2014) (9)
- External validation of the Palacios’ equation: a simple and accurate tool to estimate the new baseline renal function after renal cancer surgery (2021) (8)
- Effect of body mass index on prostate‐specific antigen and percentage free prostate‐specific antigen: Results from a prostate cancer screening cohort of 1490 men (2009) (8)
- Leydig cell tumor of the spermatic cord in an adolescent affected by congenital adrenal hyperplasia (2012) (8)
- Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma. (2020) (8)
- [18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab. (2020) (8)
- Re: Acute Kidney Injury After Partial Nephrectomy in Solitary Kidneys: Impact on Long-term Stability of Renal Function. (2019) (8)
- Parenchymal biopsy in the management of patients with renal cancer (2021) (8)
- Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation Between Ischemia Time and Patient Health Status (RECORD2 Project). (2020) (8)
- PIV-03 NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY (2014) (8)
- Surgery and erectile dysfunction. (2010) (7)
- SURE: An open label, sequential-arm, phase II study of neoadjuvant sacituzumab govitecan (SG), and SG plus pembrolizumab (pembro) before radical cystectomy, for patients with muscle-invasive bladder cancer (MIBC) who cannot receive or refuse cisplatin-based chemotherapy. (2021) (7)
- The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma. (2022) (7)
- Renal Function Assessment Gap in Clinical Practice: An Awkward Truth (2020) (7)
- Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal function. (2019) (7)
- Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. (2011) (7)
- 228 ADJUVANT RADIOTHERAPY LEADS TO SUPERIOR BIO-CHEMICAL RECURRENCE FREE SURVIVAL COMPARED TO EARLY SALVAGE RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER: RESULTS OF A MATCHED-CONTROLLED MULTI-INSTITUTIONAL ANALYSIS (2011) (7)
- Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future Insights. (2021) (7)
- Time of onset of vardenafil orodispersible tablet in a real-life setting – looking beyond randomized clinical trials (2017) (7)
- Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer. (2017) (7)
- The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial (2020) (7)
- Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years (2018) (7)
- Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis. (2020) (7)
- Omission of cortical renorrhaphy during robotic partial nephrectomy: a Vattikuti Collective Quality Initiative (VCQI) database analysis. (2020) (7)
- Renal cancer: overdiagnosis and overtreatment (2021) (7)
- When to Perform Preoperative Bone Scintigraphy for Kidney Cancer Staging: Indications for Preoperative Bone Scintigraphy. (2017) (6)
- Partial nephrectomy in frail patients: Benefits of robot-assisted surgery. (2021) (6)
- Outcomes of Partial and Radical Nephrectomy in Octogenarians - A Multicenter International Study (Resurge). (2019) (6)
- Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy. (2020) (6)
- A Nomogram for the Prediction of Intermediate Significant Renal Function Loss After Robot-assisted Partial Nephrectomy for Localized Renal Tumors: A Prospective Multicenter Observational Study (RECORd2 Project). (2021) (6)
- Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI database (2022) (6)
- Effect of obesity and overweight status on complications and survival after minimally invasive kidney surgery in patients with clinical t2 renal masses. (2020) (6)
- Percutaneous Ablation versus Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-year Follow-up. (2022) (6)
- Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer (2019) (6)
- Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project) (2017) (6)
- Kidney Cancer: Evaluation and Staging IIMP44-04 NEPHRON-SPARING SURGERY PROTECTS FROM CHRONIC KIDNEY DISEASE RELATIVE TO RADICAL NEPHRECTOMY BUT DOES NOT IMPACT ON OTHER-CAUSES MORTALITY: LONG-TERM (MORE THAN 10 YEARS) SURVIVAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH A T1A-T1B RENAL MASS (2015) (5)
- Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications. (2009) (5)
- External beam radiotherapy with or without androgen deprivation therapy in elderly patients with high metastatic risk prostate cancer. (2018) (5)
- Renal histology across the stages of chronic kidney disease (2021) (5)
- Editorial Comment to Risk factors for pelvic lymphoceles post‐radical prostatectomy (2011) (5)
- Retroperitoneal versus transepritoneal robot-assisted partial nephrectomy for postero-lateral renal masses: an international multicenter analysis (2021) (5)
- Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2018) (5)
- Estimated Glomerular Filtration Rate Decline at 1 Year After Minimally Invasive Partial Nephrectomy: A Multimodel Comparison of Predictors (2022) (5)
- Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomy. (2022) (5)
- Partial Nephrectomy for Large or Complex Masses: Option or Obsolete? (2017) (5)
- Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. (2018) (5)
- Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients. (2018) (5)
- Outcomes in robot‐assisted partial nephrectomy for imperative vs elective indications (2021) (5)
- Surgical Safety of Cytoreductive Nephrectomy Following Systemic Therapy: What Should We Look For? (2019) (5)
- The side and the location of the primary tumor does not affect the probability of lymph node invasion in patients with renal cell carcinoma (2018) (5)
- Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study. (2020) (5)
- High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? (2021) (5)
- How to Select the Optimal Candidates for Renal Mass Biopsy. (2020) (5)
- Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospective survey. (2013) (5)
- Warm ischemia time length during on-clamp partial nephrectomy: dose it really matter? (2021) (5)
- Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium (2021) (5)
- Microwave versus cryoablation and radiofrequency ablation for small renal mass: a multicenter comparative analysis. (2022) (5)
- External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88) (2021) (5)
- DEVELOPMENT AND INTERNAL VALIDATION OF THE FIRST NOMOGRAM PREDICTING LONG-TERM PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH NODE POSITIVE PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2008) (5)
- Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomogram on the RECORD2 project cohort (2022) (5)
- Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer. (2017) (5)
- 107 Nephron-sparing surgery protects from chronic kidney disease relative to radical nephrectomy but does not impact on other-causes mortality: Long-term (more than 10 years) survival and functional outcomes in patients with a T1a-T1b renal mass (2015) (4)
- Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy (2021) (4)
- Renal surgery for the older population: time for a paradigm shift? Data from the RESURGE project (2019) (4)
- Impact of Trifecta definition on rates and predictors of "successful" robotic partial nephrectomy for localized renal masses: results from the Surface-Intermediate-Base Margin Score International Consortium. (2022) (4)
- The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery (2020) (4)
- Should patients with low‐risk renal cell carcinoma be followed differently after nephron‐sparing surgery vs radical nephrectomy? (2021) (4)
- Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: A populationbased assessment (2010) (4)
- Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort. (2020) (4)
- Postoperative complications increase the risk of long‐term chronic kidney disease after nephron‐sparing surgery in patients with renal cancer and normal preoperative renal function (2019) (4)
- 559 THE EXTENT OF PELVIC LYMPH NODE DISSECTION DOES NOT AFFECT THE RATE OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RETROPUBIC RADICAL PROSTATECTOMY (2011) (4)
- Risk factors for progression of chronic kidney disease after robotic partial nephrectomy in elderly patients: results from a multi-institutional collaborative series. (2021) (4)
- Renal function outcomes in patients with muscle‐invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE‐01 study (2021) (3)
- PURE-02: An open label, multicenter, single-arm, phase 2 study of neoadjuvant pembrolizumab (Pembro), preceding radical nephroureterectomy (RNU), for patients with localized high-risk urothelial carcinoma of the upper urinary tract (UTUC) (2019) (3)
- Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity Indexes (2018) (3)
- Predicting Complications After Robotic Partial Nephrectomy: Back to Simplicity. (2021) (3)
- Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683-94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection. (2021) (3)
- External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis. (2022) (3)
- MP14-09 SURVIVAL AFTER CONSERVATIVE MANAGEMENT VERSUS EXTERNAL BEAM RADIOTHERAPY IN VERY ELDERLY PATIENTS WITH LOCALIZED PROSTATE CANCER (2016) (3)
- Onset of hydronephrosis and lower urinary tract symptoms in a previously healthy young man: Phyllodes tumour of the prostate as a potential diagnosis. (2014) (3)
- Clinical and pathological characteristics of a series of patients with newly diagnosed primary renal liposarcoma: natural history and effect on survival. (2018) (3)
- Words of wisdom. Re: Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. (2015) (3)
- Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms (2015) (3)
- External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database (2019) (3)
- Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical Outcomes. (2021) (3)
- The Association of Uromodulin Genotype with Renal Cancer Aggressiveness. (2017) (3)
- Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects (2021) (3)
- Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception? (2017) (3)
- Cytoreductive Nephrectomy in 2021: Obsolete but Necessary (2021) (3)
- Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancer. (2020) (3)
- Oncological outcomes of radical nephroureterectomy versus kidney-sparing surgery for elective treatment of clinically organ-confined upper tract urothelial carcinoma of the distal ureter. (2015) (3)
- Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy. (2009) (3)
- 471 THE NUMBER OF POSITIVE SECTION MARGINS IN HIGH-RISK PROSTATE CANCER IS A POWERFUL AND INDEPENDENT PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL IN HIGH-RISK LOCALIZED PROSTATE CANCER (2011) (3)
- 534 CANCER-SPECIFIC SURVIVAL NOMOGRAM FOR RENAL TUMORS WITH VENOUS EXTENSION:INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM (2011) (3)
- Outcomes and predictors of benign histology in patients undergoing robotic partial or radical nephrectomy for renal masses: a multicenter study (2020) (3)
- Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma (2017) (3)
- 575 Segmental ureterectomy versus radical nephroureterectomy for urothelial cancer of the ureter: A matched-pair analysis (2013) (3)
- Active surveillance for small renal masses ≤2cm: Results from an Italian multi-institutional prospective protocol (2019) (2)
- Perioperative outcomes following robot-assisted partial nephrectomy for complex renal masses: A Vattikuti Collective Quality Initiative database study (2022) (2)
- 289 Preoperative functional status predicts urinary continence recovery after radical prostatectomy (2013) (2)
- Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic Implication (2020) (2)
- Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines. (2021) (2)
- Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study (2022) (2)
- Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study. (2017) (2)
- The impact of sex and age on distribution of metastases in patients with renal cell carcinoma (2021) (2)
- MORTALITY PREDICTIONS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA (2009) (2)
- Prostate cancer in 2010: GSU: misclassification or biological progression? (2011) (2)
- 771 SHOULD AN EXTENDED NODAL TEMPLATE FOR HIGH RISK PROSTATE CANCER ALWAYS INCLUDE REMOVAL OF COMMON ILIAC LYMPH NODES? (2012) (2)
- 158 THE ROLE OF SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH [11C]CHOLINE PET/CT SCAN DETECTED NODAL RECURRENCE OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY (2010) (2)
- How to improve outcome in nephron-sparing surgery: the impact of new techniques (2021) (2)
- 660 RRP AS STAND-ALONE THERAPY FOR HIGH-RISK PROSTATE CANCER (2011) (2)
- MP42-01 A NOVEL TRIFECTA TO SIMPLIFY THE ASSESSMENT OF PERIOPERATIVE OUTCOMES AFTER ROBOT ASSISTED PARTIAL NEPHRECTOMY FOR CT1 RENAL MASSES: RESULTS OF A MULTICENTER SERIES (2019) (2)
- 959 THE IMPACT OF LOCAL AND DISTANT METASTASIS ON SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY WITH TUMOR THROMBECTOMY (2011) (2)
- PD46-03 NEGATIVE IMPACT OF POSITIVE MARGINS IN PARTIAL NEPHRECTOMY IN STAGE 1 RENAL CELL CARCINOMA: A MULTICENTER ANALYSIS (2019) (2)
- MP73-07 PREDICTION OF LYMPH NODE INVASION IN PATIENTS WITH RENAL CELL CARCINOMA: RESULTS FROM A LARGE INTERNATIONAL CONSORTIUM (2016) (2)
- The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective. (2008) (2)
- External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study (2022) (2)
- Re: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma (2016) (2)
- THE USE OF LUTEINIZING HORMONE RELEASING HORMONE AGONISTS ADMINISTRATED TO PATIENTS WITH PROSTATE CANCER PREDISPOSES TO DEMENTIA: A POPULATION-BASED ANALYSIS (2009) (2)
- ACCEPTANCE OF AND DISCONTINUATION RATE FROM PAROXETINE TREATMENT IN PATIENTS WITH LIFELONG PREMATURE EJACULATION: AN OBSERVATIONAL SURVEY AT A MAJOR TERTIARY ACADEMIC CENTRE (2009) (2)
- Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification (2022) (2)
- Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. (2015) (2)
- Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database (2020) (2)
- MP41-11 RESECTION TECHNIQUES FOR NEPHRON SPARING SURGERY (NSS) VARY: INSIGHTS FROM A PROSPECTIVELY COLLECTED MULTI-INSTITUTIONAL COHORT HARNESSING THE SURFACE–INTERMEDIATE–BASE (S.I.B.) MARGIN SCORE (SIB INTERNATIONAL CONSORTIUM) (2016) (2)
- Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy. (2022) (2)
- DISTRIBUTION OF PELVIC LYMPH NODES IS NOT SYMMETRIC. RESULTS FROM AN EXTENDED PELVIC LYMPH NODE DISSECTION SERIES (2009) (2)
- Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (2019) (2)
- A SYSTEMATIC ANALYSIS OF THE DETRIMENTAL EFFECT OF ORCHIECTOMY ON THE SKELETAL CONDITION OF MEN WITH PROSTATE CANCER (2009) (2)
- Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy. (2022) (2)
- Cytoreductive nephrectomy is dead, long live cytoreductive nephrectomy (2019) (2)
- 601 Role of conventional cytology in the treatment of upper tract urothelial carcinoma (OSS-UTUC): Results from the multi-institutional organ-sparing-UTUC collaboration (2013) (2)
- 228 Predictive molecular biomarkers of renal clear cell carcinoma (2016) (2)
- 266 Pelvic lymph node dissection can be safely omitted in men with a risk of nodal metastases ≤5% based on the Briganti nomogram: Validation of the EAU guidelines reccommendations for nodal dissection based on patient outcome (2014) (2)
- MP44-17 THE SIGNIFICANCE OF SYMPTOMATOLOGY: ANALYSIS FROM THE INTERNATIONAL RENAL CELL CARCINOMA-VENOUS THROMBUS CONSORTIUM (IRCC-VTC) (2015) (1)
- 1010 ASSESSING THE RISK OF LYMPH NODE INVASION IN PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER. A NOVEL PREDICTION TOOL (2010) (1)
- Spatial distribution of positive cores improves the selection of patients with low‐risk prostate cancer as candidates for active surveillance (2013) (1)
- PD60-03 SHOULD WE RELY ON MULTIPARAMETRIC MRI OF THE PROSTATE PERFORMED AT NON-ACADEMIC CENTRES? IMPLICATIONS FOR OPTIMIZED TARGET BIOPSY APPROACHES (2019) (1)
- Perioperative outcomes following robot-assisted partial nephrectomy in elderly patients (2022) (1)
- How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? (2022) (1)
- MP80-03 PROGNOSTIC DIFFERENCES AND SURVIVAL OUTCOMES IN PATIENTS WITH PAPILLARY RENAL CELL CARCINOMA SUBTYPES &NDASH; A COMPARISON BETWEEN TYPE I VS. TYPE II (2020) (1)
- Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression (2022) (1)
- 522 Temporal trends in the rate of lymph node dissection for renal cell carcinoma (2016) (1)
- 697 SEX HORMONE BINDING GLOBULIN IS A SIGNIFICANT PREDICTOR OF EXTRA CAPSULAR EXTENSION IN PATIENTS UNDERGOING RADICAL RETROPUBIC PROSTATECTOMY (2009) (1)
- 291 IN HIGH-RISK PROSTATE CANCER, A PELVIC LYMPH NODE DISSECTION WITH >20 LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY SIGNIFICANTLY IMPROVES OVERALL SURVIVAL (2011) (1)
- Surgical outcomes and predictors of complications in elderly patients undergoing partial or radical nephrectomy for clinically localized renal cancer: A multi-institutional analysis (RESURGE project) (2018) (1)
- Association of dividing pathologically upstaged T3a renal cell carcinoma with improved alignment of outcomes: A call for TMN revision. (2018) (1)
- 521 Impact of surgical volume on perioperative outcomes after nephrectomy with tumor thrombectomy (2016) (1)
- 751 PREOPERATIVE SEX STEROIDS ARE SIGNIFICANT PREDICTORS OF EARLY BIOCHEMICAL RECURRENCE IN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY (2011) (1)
- Where is mp-MRI more accurate in detecting clinically significant prostate cancer? An analysis based on anatomical prostate areas (2019) (1)
- B2B: Kidney Cancer Summary (2021) (1)
- Perioperative complications after partial nephrectomy for complex (PADUA score ≥ 10) renal tumors: A prospective multicenter observational study (the RECORD2 Project) (2019) (1)
- 1838 WHEN TO PERFORM LYMPH NODE DISSECTION IN RENAL CELL CARCINOMA PATIENTS: A NOVEL APPROACH TO PREOPERATIVELY ASSESS THE RISK OF LYMPH NODE INVASION AT SURGERY AND NODAL PROGRESSION DURING FOLLOW UP (2013) (1)
- NON-CANCER RELATED MORTALITY RATES IN EUROPEAN PATIENTS WITH T1A AND T1B RENAL CELL CARCINOMA (2009) (1)
- 825 Prostate health index (PHI) is more accurate than PCA3 assay in the prediction of aggressive characteristics at initial prostate biopsy (PBX) (2014) (1)
- 1023: The Role of Digital Rectal Examination in Prediction of Pathological Stage After Radical Prostatectomy in Contemporary Patients (2007) (1)
- The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates (2021) (1)
- Oncologic Surveillance for Renal Cell Carcinoma: What Is Still Needed? (2016) (1)
- EARLY FEMINIZING GENITOPLASTY: SEXUAL FUNCTION IN ADULT LIFE (2008) (1)
- Secondary analysis of PURE-01: Role of FDG-PET/CT in evaluating lymph node involvement of patients with muscle invasive bladder cancer (MIBC) receiving neoadjuvant pembrolizumab and radical cystectomy (RC). (2020) (1)
- Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium) (2019) (1)
- Negative impact of positive margins in partial nephrectomy in stage 1 renal cell carcinoma: A multicenter analysis (2019) (1)
- 762 PSYCHOSEXUAL OUTCOME IN YOUNG ADULTS WHO UNDERWENT HYPOSPADIAS SURGERY WHEN CHILDREN (2007) (1)
- Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups (2022) (1)
- A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy--A large, retrospective, single-center study. (2022) (1)
- PD51-05 ACTIVE SURVEILLANCE VS. NEPHRON SPARING SURGERY FOR SMALL RENAL MASS IN VERY ELDERLY PATIENTS: A COMPETING RISK ANALYSIS (2019) (1)
- Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas (2020) (1)
- Patterns and predictors of resection techniques during partial nephrectomy: Results of a multicenter prospective study from the Surface-Intermediate-Base (SIB) margin score international consortium (IDEAL Phase 2B) (2018) (1)
- 1616: Sex Hormone Binding Globulin: A Novel Marker for Predicting Lymph Node Metastases in Patients with Clinically Localized Prostate Cancer Undergoing an Extended Pelvic Lymph Node Dissection (2007) (1)
- RACE, GENDER AND REGIONAL VARIABILITY IN THE USE OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: A POPULATION-BASED ANALYSIS (2009) (1)
- Simplified PADUA renal (SPARE) nephrometry score validation and long-term outcomes after robot-assisted partial nephrectomy. (2021) (1)
- Is Hypertension Associated with Worse Renal Functional Outcomes after Minimally Invasive Partial Nephrectomy? Results from a Multi-Institutional Cohort (2022) (1)
- ON‐CLAMP VERSUS OFF‐CLAMP PARTIAL NEPHECTOMY: PROPENSITY SCORE MATCHED COMPARISON OF LONG TERM FUNCTIONAL OUTCOMES: MP49‐08 (2017) (1)
- 1831 THE NUMBER OF LYMPH NODES REMOVED IN RENAL CELL CARCINOMA DOES AFFECT CANCER SPECIFIC SURVIVAL IN SPECIFIC SUBGROUPS OF PATIENTS: RESULTS FROM A SYSTEMATIC ANALYSIS (2013) (1)
- IS THERE AN AGE LIMIT FOR THE INDICATION OF EXTENDED PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER?: MP64‐10 (2017) (1)
- HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN) ON INITIAL PROSTATE BIOPSY IS NOT A RISK FACTOR FOR PROSTATE CANCER AT REPEAT BIOPSY (2009) (1)
- MP42-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR CT2 RENAL TUMORS: PERIOPERATIVE, FUNCTIONAL AND ONCOLOGICAL OUTCOMES FROM A MULTICENTER ANALYSIS (THE ROSULA PROJECT) (2018) (1)
- A snapshot of nephron sparing surgery in Italy: A prospective, multicenter report on clinical and operative data (the RECORD 2 project) (2018) (1)
- 752 ADJUVANT RADIOTHERAPY HAS NO IMPACT ON BIOCHEMICAL RECURRENCE FREE SURVIVAL IN PROSTATE CANCER PATIENTS WITH SEMINAL VESICLES INVASION TREATED WITH RADICAL PROSTATECTOMY (2009) (1)
- Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience. (2020) (1)
- 1008 PARTIAL CYSTECTOMY DOES NOT UNDERMINE CANCER CONTROL IN APPROPRIATELY SELECTED PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER: A POPULATION-BASED MATCHED ANALYSIS (2009) (1)
- Robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter outcome analysis (2020) (1)
- Perioperative, functional and oncological outcomes of robot-assisted partial nephrectomy for cT2 renal tumors: A multicenter analysis (The ROSULA project) (2018) (1)
- MP36-12 WHERE IS MP-MRI MORE ACCURATE IN DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER? AN ANALYSIS BASED ON ANATOMICAL PROSTATE AREAS (2019) (1)
- 1760 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS. INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM (2011) (1)
- Minimally invasive partial nephrectomy for elderly patients with renal mass: Morbidity, renal function and oncologic outcomes in the resurge collaborative database (2018) (1)
- Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: The impact of nephrons loss (2018) (1)
- A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. (2022) (1)
- A nomogram for the prediction of significant long-term renal function loss after robot-assisted partial nephrectomy for localized renal tumors: A prospective multicenter observational study (RECORd2 project) (2021) (1)
- The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy (2022) (1)
- 263 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS (2011) (1)
- When to perform preoperative bone scan for kidney cancer staging (2016) (1)
- ANDROGEN DEPRIVATION THERAPY DOES NOT PREDISPOSE TO OSTEOPENIA IN PROSTATE CANCER PATIENTS (2008) (1)
- MP59-16 ROBOTIC VERSUS LAPAROSCOPIC RADICAL NEPHRECTOMY: A MATCHED PAIRED MULTICENTER ANALYSIS (ROSULA GROUP) (2018) (1)
- Editorial comment on: Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries. (2009) (1)
- Neoadjuvant Treatment in Renal Cell Carcinoma: Transforming Challenges into Opportunities. (2022) (1)
- PD40-07 CLINICAL OUTCOMES AND ADVERSE EVENTS AFTER FIRST-LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (2021) (1)
- Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma (2021) (1)
- Editorial Comment to Nodal involvement at nephrectomy is associated with worse survival: A stage‐for‐stage and grade‐for‐grade analysis (2013) (1)
- Ischemia time during partial nephrectomy has a different impact on renal function loss according to preoperative risk of acute kidney injury. Results from a prospective multicenter observational study (the RECORD2 project) (2019) (1)
- TESTING THE MOST STRINGENT CRITERIA FOR ACTIVE SURVEILLANCE: AN ANALISIS BASED ON PATHOLOGICAL FEATURES AT RADICAL PROSTATECTOMY (2009) (1)
- Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery. (2018) (1)
- 971 THE EFFECT OF BODY MASS INDEX ON HISTOPATHOLOGICAL PARAMETERS; RESULTS OF A LARGE EUROPEAN CONTEMPORARY CONSECUTIVE OPEN RADICAL PROSTATECTOMY SERIES (2009) (1)
- Against the Role of Inflammatory Markers in Renal Cell Carcinoma Prognosis: The Missing Link Between Evidence of Association and Clinical Applicability. (2016) (1)
- 841 A SYSTEMATIC ANALYSIS OF THE DETRIMENTAL EFFECT OF ORCHIECTOMY ON 12 SYSTEMIC MORBIDITIES (2009) (1)
- SP018THE ASSOCIATION OF UROMODULIN GENOTYPE WITH RENAL CANCER AGGRESSIVENESS (2017) (1)
- Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity. (2022) (1)
- Cytoreductive Nephrectomy in the Era of Targeted Therapy and Immunotherapy (2022) (1)
- Head to head impact of MIC vs a novel TRIFECTA score on oncologic and functional outcomes after robotic assisted partial nephrectomy: Results of a multicentric series (2019) (1)
- CRITICAL ANALYSIS AND ASSESSMENT OF CLINICAL UTILITY OF NEPHROMETRY SCORES FOR THE PREDICTION OF COMPLICATIONS AFTER NEPHRON SPARING SURGERY: MP59‐05 (2017) (1)
- MP77-01 WHICH PATIENTS WITH PIRADS 3 LESION AT MULTIPARAMETRIC MRI CAN AVOID PROSTATE BIOPSY? (2018) (1)
- Oncologic outcomes after robot-assisted partial nephrectomy in the iron study: results from a large, global, multicentric analysis of patients with clinically localized kidney cancer (2020) (1)
- Adjuvant RT is associated with better cancer control compared to early salvage RT in patients with prostate cancer: results of a matched-controlled multi-institutional analysis (2010) (1)
- Active surveillance vs. nephron sparing surgery for small renal mass in very elderly patients: A competing risk analysis (2019) (1)
- 978 ACCEPTANCE OF AND DISCONTINUATION RATE FROM PAROXETINE TREATMENT IN PATIENTS WITH LIFELONG PREMATURE EJACULATION: AN OBSERVATIONAL SURVEY AT A MAJOR TERTIARY ACADEMIC CENTRE (2009) (1)
- Which patients with PI-RADs 3 lesion at multiparametric MRI can avoid prostate biopsy (2018) (1)
- MP21-02 THE IMPACT OF INTRAOPERATIVE BLEEDING ON THE RISK OF CHRONIC KIDNEY DISEASE AFTER NEPHRON-SPARING SURGERY (2020) (1)
- Surgeon assessment of volume preservation (SAVP) performed before or after partial nephrectomy to predict post-operative renal function. (2016) (1)
- Identifying patients for adjuvant therapy after nephrectomy (2022) (1)
- 118 REMOVAL OF AT LEAST 8 NODES IMPROVES BOTH STAGING AND OUTCOMES IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA (2009) (1)
- Should we rely on multiparametric MRI of the prostate performed at non-academic centres? Implications for optimized target biopsy approaches (2019) (1)
- MP30-01 DECREASING RATES OF LYMPH NODE DISSECTION AND LYMPH NODE YIELD DURING RADICAL NEPHRECTOMY FOR RENAL CELL CARCINOMA OVER THE LAST 30 YEARS IN A LARGE MULTICENTRE EUROPEAN EXPERIENCE (2014) (1)
- Risk-based surveillance after surgical treatment of renal cell carcinoma (2018) (1)
- Oncologic and functional outcomes of radical and partial nephrecotmy in PT3A patholigically upstaged renal cell carcinoma: A multi-instituitional analysis. (2018) (1)
- 300 When to perform a staging chest-CT scan before surgical treatment for kidney cancer (2016) (1)
- Perioperative morbidity of open, laparoscopic and robotic partial nephrectomy: A prospective multicenter observational study (RECORD 2) (2019) (1)
- Von Hippel–Lindau disease-associated renal cell carcinoma: a call to action (2021) (1)
- You Can Trust a Crystal Ball About as Far as You Can Throw It. (2018) (1)
- 779 Nodal yield during robotic-assisted laparoscopic radical prostatectomy. Is there an improvement with surgical expertise? (2012) (0)
- Comment on: Capitanio et al.: Cytoreductive Partial Nephrectomy Does Not Undermine Cancer Control in Metastatic Renal Cell Carcinoma : A Population-based Study. Authors' reply (2009) (0)
- MP15-05 TOPOGRAPHIC DESCRIPTION OF THE SITE OF POSITIVE MPMRI AND IMPACT ON THE RISK OF POSITIVE SURGICAL MARGINS AT ROBOT-ASSISTED NERVE SPARING RADICAL PROSTATECTOMY. IMPLICATIONS FOR ACCURATE SURGICAL APPROACHES (2022) (0)
- PD15-09 PELVIC LYMPH NODE DISSECTION CAN BE SAFELY OMITTED IN MEN WITH A RISK OF NODAL METASTASES ≤5% BASED ON THE BRIGANTI NOMOGRAM: VALIDATION OF THE EAU GUIDELINS RECCOMENDATIONS FOR NODAL DISSECTION BASED ON PATIENT OUTCOME (2014) (0)
- Impact of surgical approach (open vs. minimally invasive) on oncological outcomes after nephrectomy for localized renal cell carcinoma: A RECUR database project (2021) (0)
- Prostate Cancer: Staging IIIModerated Poster 11395 ASSESSING THE RISK OF LYMPH NODE INVASION IN PATIENTS WITH INTERMEDIATE RISK PROSTATE CANCER. A NOVEL PREDICTION TOOL (2010) (0)
- NEPHRON SPARING SURGERY DOES NOT ALWAYS DECREASE OTHER-CAUSES MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH NORMAL PREOPERATIVE RENAL FUNCTION (2014) (0)
- Impact of implementation of the EAU guidelines panel recommendations on reporting and grading of complications on perioperative outcomes after robot-assisted radical prostatectomy (2018) (0)
- 408: Prognostic Value of Lymphnode Dissection in Patients with Muscle-Invasive Transitional Cell Carcinoma of the Upper Urinary Tract (2007) (0)
- Impact of intraoperative blood transfusions on survival after surgery for renal cell carcinoma (2017) (0)
- 2235 THE NUMBER OF BIOPSY CORES TAKEN IS A MAJOR PREDICTOR OF UNFAVORABLE PROSTATE CANCER AT FINAL PATHOLOGY IN PATIENTS CANDIDATE FOR ACTIVE SURVEILLANCE: CLINICAL IMPLICATIONS (2013) (0)
- Perc-score as a nephrometry scoring system in percutaneous tumour ablation: comparison with renal, mrenal, padua and spare in a multi-centre series (2022) (0)
- MP59-10 COMPARISON OF RENAL FUNCTIONAL OUTCOMES AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR COMPLEX RENAL MASS: ANALYSIS FROM THE ROSULA (ROBOTIC SURGERY FOR LARGE RENAL MASS) COLLABORATIVE GROUP (2021) (0)
- 58 Intrafascial technique offers improved functional outcomes in patients treated with bilateral nerve sparing robotic radical prostatectomy (2011) (0)
- MP-04 . 02 Utilizing fractional polynomials to predict post-chemotherapy retroperitoneal lymph node dissection pathology (2016) (0)
- Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery (2022) (0)
- Robotic vs. open partial nephrectomy for highly complex renal masses: Results from a multicenter prospective observational study (The SIB International Consortium) (2020) (0)
- MP24-12 RISKS ASSESSMENT OF SIGNIFICANT RENAL FUNCTION DETERIORATION AFTER PARTIAL NEPHRECTOMY AND CALL FOR RECONSIDERING THE IMPERATIVE SETTING (2022) (0)
- 609 AGE ADJUSTED VALIDATION OF THE MOST STRINGENT CRITERIA FOR ACTIVE SURVELLIANCE: IMPLICATIONS FOR PATIENT SELECTION (2010) (0)
- Describing long-term functional and oncologic outcomes of robot-assisted partial nephrectomy: the roma score (2020) (0)
- CHANGES OVER TIME IN NODE POSITIVE PROSTATE CANCER RATES AND FEATURES AMONG MEN TREATED WITH RADICAL PROSTATECTOMY AND EXTENTED PELVIC LYMPH NODE DISSECTION AT A SINGLE REFERRAL CENTER: MP97‐12 (2017) (0)
- MP59-01 NEPHRON SPARING SURGERY DOES NOT DECREASE OTHER-CAUSES MORTALITY RELATIVE TO RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY (2014) (0)
- 1637 SEMINAL VESICLE PRESERVATION DOES NOT IMPROVE FUNCTIONAL OUTCOME OF PATIENTS TREATED WITH BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY (2011) (0)
- Comparative analysis of outcomes of papillary type 1 and type 2 and clear cell renal cell carcinoma: A multi-institutional study (2018) (0)
- 231 POST-TREATMENT NOMOGRAM FOR PREDICTION OF CONDITIONAL SURVIVAL AFTER NEPHRECTOMY (2009) (0)
- IS A PREOPERATIVE LOW EJECTION FRACTION A RISK FACTOR FOR COMPLICATIONS AND IMPAIRED SURVIVAL IN RENAL CANCER PATIENTS WHO UNDERGO SURGERY? RESULTS FROM A PROPENSITY‐SCORE MATCHING WITH NON CARDIOPATHIC COUNTERPARTS: MP67‐17 (2017) (0)
- PD49-09 COMPARATIVE ANALYSIS OF RENAL FUNCTIONAL OUTCOMES OF ACTIVE SURVEILLANCE AND PARTIAL NEPHRECTOMY IN THE MANAGEMENT OF ONCOCYTOMA: AN INTERNATIONAL MULTICENTER ANALYSIS (2020) (0)
- PD28-07 ASSESSMENT OF THE RATE OF ADHERENCE TO INTERNATIONAL GUIDELINES OF ANDROGEN DEPRIVATION THERAPY WITH EXTERNAL BEAM RADIATION THERAPY- A POPULATION-BASED STUDY (2016) (0)
- PD57-11 IDENTIFICATION OF THE BEST CANDIDATES FOR PSMA PET/CT AMONG PATIENTS EXPERIENCING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2021) (0)
- It is time to differentiate the follow-up schedule of low-risk renal cell carcinoma according to the histological subtype (2018) (0)
- PD41-05 PROPENSITY SCORE MATCHED COMPARISON OF MINIMALLY INVASIVE PARTIAL AND RADICAL NEPHRECTOMY FOR CLINICAL T2A RENAL MASS: ANALYSIS OF THE ROBOTIC SURGERY FOR LARGE RENAL MASSES (ROSULA) GROUP (2019) (0)
- Benign Prostatic Hyperplasia: Surgical Therapy and New TechnologyPodium 56: Wednesday, May 18, 2011: 1:00 PM-3:00 PM2271 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES (2011) (0)
- MP63-20 DEVELOPMENT AND EXTERNAL VALIDATION OF A PATHOLOGICAL NODAL STAGING SCORE FOR PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA (2015) (0)
- CAN WE MODULATE THE EXTENT OF NODAL DISSECTION ACCORDING TO THE PREOPERATIVE RISK OF LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY?: MP97‐10 (2017) (0)
- 1742 OUTCOME OF PATIENTS POTENTIALLY SUITABLE FOR ACTIVE SURVEILLANCE UNDERGOING RADICAL PROSTATECTOMY AS FIRST TREATMENT CHOICE. RESULTS OF INTERMEDIATE-TERM FOLLOW-UP (2010) (0)
- Postoperative outcomes and two-year renal function in patients with limited life expectancy treated with partial nephrectomy for renal tumors: Analysis of predictors and comparison with patients with longer life expectancy (the record 2 project) (2019) (0)
- Assessing predictors of chronic kidney disease progression in patients receiving minimally-invasive partial nephrectomy: Results of a multi-institutional collaborative series (2021) (0)
- Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma. (2022) (0)
- The effect of anatomical location of retroperitoneal lymph node metastases on cancer specific survival in patients with clear cell renal cell carcinoma (2017) (0)
- 1379 THE KEY ROLE OF TIME IN PREDICTING POST-RADICAL PROSTATECTOMY ERECTILE FUNCTION RECOVERY: CONDITIONAL SURVIVAL ANALYSES (2012) (0)
- Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial (2023) (0)
- Reply from Authors re: Evangelos Liatsikos, Panagiotis Kallidonis. Laparoscopic or Open Nephroureterectomy? Which is the More Efficient Way to go? Eur Urol 2009;56:10–12 (2009) (0)
- PD29-09 PARTIAL NEPHRECTOMY IN A COHORT OF “ENUCLEORESECTIVE” CENTERS: INSIGHTS FROM THE SURFACE–INTERMEDIATE–BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM (2016) (0)
- ESTIMATED GLOMERULAR FILTRATION RATE: DO WE MEASURE THE REAL RENAL FUNCTION OR ARE WE STILL GROPING IN THE DARK?: MP22‐08 (2017) (0)
- The best of uro-oncology in 2016 - Kidney cancer (2017) (0)
- MP22-10 WHICH POSITIVE SURGICAL MARGINS FEATURES IMPACT ON THE RISK OF PROSTATE CANCER SPECIFIC MORTALITY? A DISEASE-TAILORED, COMPETING-RISK, LONG-TERM ANALYSIS (2019) (0)
- MP40-14 PREDICTORS OF CANCER-SPECIFIC SURVIVAL AFTER DISEASE RECURRENCE IN PATIENTS WITH RENAL CELL CARCINOMA: THE EFFECT OF TIME TO RECURRENCE (2014) (0)
- MP78-15 BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: WHO IS AT RISK OF DYING FROM PROSTATE CANCER? (2015) (0)
- External validation of the VENUSS prognostic model to predict disease recurrence after surgery for non-metastatic papillary renal cell carcinoma: An analysis of a multi-institutional European cohort (2021) (0)
- SP236THE RADICAL NEPHRECTOMY PARADOX: THE UNEXPECTED AKI'S RISK (2019) (0)
- Hypertension and cardiovascular morbidity following radical nephrectomy are only sustained by renal parenchyma loss and cardiovascular morbidity (2020) (0)
- Development of a biomarker-based calculator to predict the probability to achieve a pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer (2019) (0)
- 294 IN HIGH-RISK PROSTATE CANCER, 3 OR MORE POSITIVE NODES AT RADICAL PROSTATECTOMY REPRESENT AN INDEPENDENT PREDICTOR OF WORSE CSS, WHILE 1 OR 2 POSITIVE NODES DO NOT INFLUENCE CSS (2014) (0)
- 828 CAN WE PREDICT LYMPHORRHEA AND CLINICALLY SIGNIFICANT LYMPHOCELES AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2010) (0)
- Acute kidney injury after partial nephrectomy: Epidemiology, predictive factors and implications for clinical practice (2019) (0)
- 930 AGE ADJUSTED VALIDATION OF THE MOST STRINGENT CRITERIA FOR ACTIVE SURVELLIANCE: IMPLICATIONS FOR PATIENT SELECTION (2010) (0)
- The role of non-tumour renal biopsy in patients treated with radical nephrectomy (2019) (0)
- 500 IMPACT OF TUMOR THROMBUS CONSISTENCY (SOLID VS FRIABLE) ON CANCER-SPECIFIC MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2011) (0)
- PD18-03 PROPOSAL FOR RECLASSIFICATION OF T1 AND T2A RENAL CELL CARCINOMA: RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS (2022) (0)
- 238 SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2009) (0)
- Added value of concomitant systematic biopsies in predicting upgrading in patients with localized prostate cancer diagnosed by MRI-targeted biopsy: Implications for treatment selection (2019) (0)
- MP50-09 IMAGING INTENSITY AFTER SURGERY FOR CLEAR CELL RENAL CELL CARCINOMA (2022) (0)
- THE NUMBER OF BIOPSY CORES REPRESENTS ONE OF THE FOREMOST PREDICTOR OF CLINICALLY SIGNIFICANT GLEASON SUM UPGRADING IN LOW RISK PROSTATE CANCER PATIENTS (2009) (0)
- Comparison of robot-assisted partial nephrectomy and percutaneous ablation for ct1 renal masses: Mid term outcome analysis (2021) (0)
- The ERUS curriculum for robot-assisted partial nephrectomy: Structure definition and pilot clinical calidation (2019) (0)
- Corrigendum to "The Importance of Interaction Between Urologists and Pathologists in Incidental Prostate Cancer Management" [Eur Eurol 2011;60;75-7]. (2012) (0)
- External validation of the Mayo Clinic Stage, Size, Grade, and Necrosis score in patients with renal cell carcinoma and venous tumor thrombus (2017) (0)
- 932 THERE IS NO WAY TO IDENTIFY PATIENTS WHO WILL HARBOR PT2A PROSTATE CANCER AT RADICAL PROSTATECTOMY. IMPLICATIONS FOR FOCAL THERAPIES (2010) (0)
- TaggedH1Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset TaggedEnd (2020) (0)
- Are We Ready For A Multicultural Society? The Case For Multiculturalism In Sexual And Parenting Relationships (2014) (0)
- 115 THE ACCURACY OF THE PERCENTAGE OF POSITIVE CORES IN PREDICTING ADVANCED PROSTATE CANCER DOES NOT CHANGE ACCORDING TO THE EXTENT OF BIOPSY SCHEME (2010) (0)
- MP50-11 HEAD TO HEAD COMPARISON BETWEEN OFF-CLAMP VS ON-CLAMP RAPN IN HIGH-RISK RENAL SCORE KIDNEY TUMORS (2022) (0)
- MP47-12 FRAILTY STATUS PREDICTS WORSE POSTOPERATIVE AND LONG-TERM ONCOLOGIC OUTCOMES IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY FOR SMALL RENAL MASSES (2022) (0)
- MP80-11 CLINICAL, SURGICAL, PATHOLOGICAL AND FOLLOW-UP FEATURES OF KIDNEY CANCER IN PATIENTS WITH VON HIPPEL-LINDAU SYNDROME: NOVEL INSIGHTS FROM A LARGE EUROPEAN CONSORTIUM (2020) (0)
- 740 UNSUCCESSFUL INVESTIGATION OF PREOPERATIVE COUPLES AND SEXUAL RELATIONSHIP ISSUES IN CANDIDATES TO RADICAL PROSTATECTOMY (2007) (0)
- Platinum Priority – Review – Kidney Cancer (2018) (0)
- P-01-041 Changes in sexual function and mental health after renal cancer surgery: A pilot study (2017) (0)
- The current role of renal tumor biopsy in small renal masses: long-term results from a prospective, single-institutional database (2022) (0)
- Comparison of robot-assisted and open surgery partial nephrectomy: An observational prospective study on pathologic and early functional outcomes (2017) (0)
- 634 Does an unexpected final pathology of pT3a renal tumour undermine cancer control in clinically T1N0M0 patients who were initially treated with nephron sparing surgery (2016) (0)
- 620 PATHOLOGICAL GLEASON SCORE DICTATES SURVIVAL IN PATIENTS WITH SEMINAL VESICLE INVASION TREATED WITH RADICAL PROSTATECTOMY AND ADJUVANT RADIATION THERAPY. RESULTS FROM A TWO-INSTITUTION SERIES ANALYSIS (2010) (0)
- 95 Staging lymphadenectomy in renal cell carcinoma must be extended: A sensitivity curve analyses (2012) (0)
- Clinical and surgical predictors of medical and surgical postoperative complications in patients with limited life expectancy treated with partial nephrectomy for renal tumors: Insight from the RECORD2 project (2019) (0)
- 709 MORE EXTENSIVE PELVIC LYMPH NODE DISSECTION IS ASSOCIATED WITH REDUCED RISK OF CANCER PROGRESSION IN NODE NEGATIVE ORGAN CONFINED PROSTATE CANCER PATIENTS (2011) (0)
- MO133RENAL FUNCTIONAL OUTCOMES AT 5 YEARS FROM RADICAL AND PARTIAL NEPRHECTOMIES IN NORMAL RENAL FUNCTION PATIENTS : AN UNTOLD STORY OF FAILED RENAL HYPERFILTRATIONS (2021) (0)
- Does prostate cancer represent the main cause of death in all node positive prostate cancer patients? The impact of competing causes of mortality according to tumor characteristics and recurrence status (2017) (0)
- The effect of obesity and overweight status on complications and survival after minimally invasive kidney surgery in patients with clinical T2 renal masses: Evidences from rosula dataset (2019) (0)
- Oncologic and functional outomes of radical and partial nephrectomy in pT3a pathologically upstaged renal cell carcinoma: A multi institutional analysis (2018) (0)
- 518 Contemporary analysis of comorbid diseases used to define Charlson comorbidity index score among radical cystectomy candidates (2016) (0)
- Off-clamp versus on-clamp robot-assisted partial nephrectomy: A propensity-matched analysis (2023) (0)
- Trifecta achievement after partial nephrectomy helps predicting long term oncologic and functional outcomes: a multicenter study (2020) (0)
- MP64-13 IMPACT OF SURGICAL VOLUME ON PERIOPERATIVE OUTCOMES AFTER NEPHRECTOMY WITH TUMOR THROMBECTOMY (2016) (0)
- PD07-07 NEPHROMETRY ADJUSTED COMPARISON OF PERIOPERATIVE AND FUNCTIONAL OUTCOMES BETWEEN ON CLAMP VS OFF-CLAMP ROBOT-ASSISTED PARTIAL NEPHRECTOMY (2023) (0)
- MP58-01 DO OPEN AND MINIMALLY INVASIVE TECHNIQUES AFFECT PROGNOSIS AND SURVIVAL OUTCOMES IN PATIENTS UNDERGOING CURATIVE SURGERY FOR NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA? COMPARATIVE ANALYSIS OF A MATCHED-PAIR COHORT FROM A MULTI-INSTITUTIONAL DATABASE (2023) (0)
- Which positive surgical margins features impact on the risk of prostate cancer specific mortality? A disease-tailored, competing-risk, long-term analysis (2019) (0)
- SIGIRR Downregulation and Interleukin-1 Signaling Intrinsic to Renal Cell Carcinoma (2022) (0)
- Factors predicting renal function after partial nephrectomy: A multi-institutional analysis of data from the SIB working group. (2016) (0)
- MP12-07 THE ANATOMICAL LOCATION OF LYMPHADENOPATHIES AT IMAGING PREDICTS THE RISK OF LYMPH NODE INVASION AT FINAL PATHOLOGY IN PATIENTS WITH RENAL CELL CARCINOMA (2022) (0)
- MP49-10 IMPACT OF SURGICAL APPROACH (OPEN VS. MINIMALLY INVASIVE) ON ONCOLOGICAL OUTCOMES AFTER NEPHRECTOMY FOR LOCALISED RENAL CELL CARCINOMA: A RECUR DATABASE PROJECT (2021) (0)
- 469 ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCE (2011) (0)
- 137 PADUA score accurately predicts the risk and grade of complication and ischemic time in patients who are candidates for nephron sparing surgery (2012) (0)
- Decision-making and management strategies for patients with bilateral synchronous non-metastatic renal masses: Insights from a multi-centre European dataset (2022) (0)
- 675 A COMPARATIVE SURVIVAL ANALYSIS OF NON BILHARZIAL SQUAMOUS CELL CARCINOMA VS. TRANSITIONAL CELL CARCINOMA AFTER CYSTECTOMY (2009) (0)
- How important are morphologic subtypes on the prognosis of surgically treated non-metastatic papillary renal cell carcinoma? An analysis from a contemporary multi-institutional database (2022) (0)
- 372 THE NUMBER OF POSITIVE NODES IS THE STRONGEST PREDICTOR OF CANCER SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR PATHOLOGICAL T3 PROSTATE CANCER (2013) (0)
- MO165: The Controversial Role of Proteinuria and Urinary Output After Radical Nephrectomy in the Development Of Acute Kidney Injury: Double Agents (2022) (0)
- SUN-026 THE RADICAL NEPHRECTOMY PARADOX: THE UNEXPECTED AKI RISK (2020) (0)
- Adherence to guidelines in the management of high-risk non- muscle-invasive bladder cancer: Are patients receiving intravesical Bacillus Calmette-Guérin therapy appropriately? (2021) (0)
- MP64-02 COMPARISON OF ONCOLOGIC OUTCOMES AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR CT2 RENAL CELLS CARCINOMA. (2016) (0)
- 926 TIME FROM PROSTATE BIOPSY TO RADICAL PROSTATECTOMY REPRESENTS AN INDEPENDENT PREDICTOR OF PROSTATE CANCER SIGNIFICANT UPGRADING (2009) (0)
- Which patients with clinically node prostate cancer benefit from radical prostatectomy? The impact of the size and site of nodal involvement on long-term outcomes (2018) (0)
- Impact of the time elapsed between prostate biopsy and surgery on the accuracy of the Briganti nomogram predicting lymph node invasion in men with clinically localized prostate cancer (2022) (0)
- SUN-209 CHRONIC KIDNEY DISEASE CLASSIFICATION: IS THE CORRECT METHOD TO DEFINE RENAL DAMAGE OR IS IT JUST AN ILLUSION? (2019) (0)
- Preoperative estimation of long-term oncologic outcomes in patients treated with surgery for kidney cancer (2018) (0)
- Perioperative morbidity and complications after robot-assisted and open surgery partial nephrectomy: An observational prospective study (2017) (0)
- 733 MORTALITY PREDICTIONS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA (2009) (0)
- When can we de-intensify treatments in ISUP Grade Group 5 prostate cancer? Long-term results of a single center, high volume series (2022) (0)
- PELVIC LYMPH NODE DISSECTION SHOULD BE OMITTED IN LOW RISK PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS (2009) (0)
- MP28-16 GENERALIZABILITY OF THE MK-6482-004 TRIAL TO REAL-WORLD VHL PATIENTS: RESULTS FROM A PROSPECTIVE SURVEILLANCE STUDY (2023) (0)
- Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma. (2022) (0)
- A new proposal to improve the surveillance of renal cell carcinoma patients after surgery (2018) (0)
- MP42-17 ONCOLOGIC AND FUNCTIONAL OUTCOMES OF RADICAL AND PARTIAL NEPHRECTOMY IN PT3A PATHOLOGICALLY UPSTAGED RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL ANALYSIS (2018) (0)
- MP50-02 HOW IMPORTANT ARE MORPHOLOGIC SUBTYPES ON THE PROGNOSIS OF SURGICALLY TREATED NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA? AN ANALYSIS FROM A CONTEMPORARY MULTI-INSTITUTIONAL DATABASE (2022) (0)
- The prognostic significance of persistently elevated PSA after radical prostatectomy is highly associated with pathological stage: Implications for timely use of salvage treatments (2018) (0)
- Oncologic outcomes in patients diagnosed with pT3a non-metastatic renal cell cancer according to renal vein thrombus or fat invasion (2022) (0)
- SP045CHRONIC KIDNEY DISEASE CLASSIFICATION: IS THE CORRECT METHOD TO DEFINE RENAL DAMAGE OR IS IT JUST AN ILLUSION? (2018) (0)
- MP14-06 THE IMPACT OF ADJUVANT RADIOTHERAPY ON CANCER-SPECIFIC MORTALITY IN PROSTATE CANCER PATIENTS WITH SEMINAL VESICLE INVOLVEMENT: A COMPETING-RISKS REGRESSION ANALYSIS (2016) (0)
- When to omit lymphadenectomy during radical prostatectomy in patients with clinical localized prostate cancer: A clinical net benefit analysis weighting staging accuracy, risk of morbidity and life expectancy (2020) (0)
- 646 Nephron sparing surgery does not decrease other-causes mortality relative to radical nephrectomy in patients with clinical T1a-T1b renal mass: Results from a large multi-institutional study (2014) (0)
- MP58-13 FUNCTIONAL OUTCOMES AFTER SURGERY IN PATIENTS WITH RENAL CANCER AND TUMOR THROMBUS (2023) (0)
- Pre-operative risk calculator for the probability of completing surgery for kidney cancer: The key role of tumour complexity and surgical experience (2023) (0)
- 248 The Impact of Renal Cancer Diagnosis and Planned Treatment (Radical vs Partial Nephrectomy) Over Sexual Health and Mood (2017) (0)
- MP42-05 PERIOPERATIVE COMPLICATIONS AFTER PARTIAL NEPHRECTOMY FOR COMPLEX (PADUA SCORE ≥ 10) RENAL TUMORS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY (THE RECORD2 PROJECT) (2019) (0)
- Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience (2022) (0)
- PURE-02: An open-label, single-arm, feasibility study of neoadjuvant pembrolizumab before Radical Nephroureterectomy (RNU) in patients with high-risk, Upper-Tract Urothelial Carcinoma (UTUC) (2021) (0)
- PD40-12 FUNCTIONAL OUTCOMES PREDICTION AFTER ROBOTIC PARTIAL NEPHRECTOMY USING PADUA SCORE ASSESSED WITH 3D VIRTUAL MODELS: PRELIMINARY RESULTS OF A COLLABORATIVE ERUS STUDY (2023) (0)
- 1628 AT LEAST ONE PHOSPHODIESTERASE TYPE 5 INHIBITOR DOSE PER WEEK SHOULD BE TAKEN IN ORDER TO IMPROVE ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2011) (0)
- 744 The number of cores taken at first negative biopsy does not affect the cancer detection rate at saturation repeat biopsy in patients with persistent suspicion of prostate cancer (2014) (0)
- Neutrophil to lymphocyte ratio is associated with lymph node invasion and higher nodal burden in contemporary high risk patients treated with radical prostatectomy and extended pelvic lymph node dissection (2018) (0)
- 341 INTRA-OPERATIVE AND FUNCTIONAL RESULTS OF ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. COMPARISON OF SURGEONS WITH DIFFERENT OPERATIVE BACKGROUNDS (2011) (0)
- 865 Predictive factors of resection techniques during partial nephrectomy in a cohort of “enucleative” centres: Insights from the Surface–Intermediate–Base (SIB) Margin score International Consortium (2016) (0)
- PD33-12 PRE-OPERATIVE RISK CALCULATOR OF THE PROBABILITY OF COMPLETING NEPHRON-SPARING SURGERY FOR KIDNEY CANCER BASED ON TUMOUR COMPLEXITY AND SURGICAL APPROACH (2022) (0)
- THE EFFECT OF ANATOMICAL LOCATION OF RETROPERITONEAL LYMPH NODE METASTASES ON CANCER SPECIFIC SURVIVAL IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA: PD04‐04 (2017) (0)
- MP15-01 CONTEMPORARY ANALYSIS OF MEDICARE REIMBURSEMENTS RELATED TO TREATMENT OF LOCALIZED PROSTATE CANCER (2016) (0)
- ONCOLOGIC AND SURVIVAL OUTCOMES FOR PATHOLOGIC T3A UPSTAGING IN CLINICALLY LOCALIZED RENAL MASSES: DOES PARTIAL NEPHRECTOMY INCREASE ONCOLOGICAL RISK?: PD20‐07 (2017) (0)
- Predictors of trifecta after open and robot partial nephrectomy for highly complex localized renal tumor: results from a large multicenter international prospective observational project (the surface-intermediate-base margin score consortium) (2020) (0)
- 899 DOES BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY AND ADJUVANT RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER INVARIABLY IMPACT CANCER-SPECIFIC MORTALITY? (2011) (0)
- 788 NERVE-SPARING TECHNIQUE DURING RADICAL PROSTATECTOMY IS STRONGLY ASSOCIATED WITH THE RATE OF URINARY CONTINENCE RECOVERY. LONG TERM FOLLOW UP OF A SINGLE TERTIARY CARE CENTER (2011) (0)
- REPLY (2012) (0)
- NATURAL HISTORY OF SURGICALLY TREATED LOCAL RECURRENCE AFTER NEPHRECTOMY: MP16‐15 (2017) (0)
- Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.002 (2022) (0)
- Editorial Comment. (2019) (0)
- Sustainable multidisciplinary team referral for non-metastatic renal cell carcinoma: A survival-based recommendation (2022) (0)
- RACE AND GENDER DO NOT AFFECT THE CANCER-SPECIFIC SURVIAL AFTER SURGERY IN PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA (2009) (0)
- Clinical outcome after radical metastasectomy in renal cell carcinoma: Results from a randomized phase 2 study (2019) (0)
- MP49-16 COMPARISON OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY AND PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES: MID TERM OUTCOME ANALYSIS (2021) (0)
- PD29-03 DOES AN UNEXPECTED FINAL PATHOLOGY OF PT3A RENAL CARCINOMA UNDERMINE CANCER CONTROL IN CLINICALLY T1N0M0 PATIENTS WHO WERE INITIALLY TREATED WITH NEPHRON SPARING SURGERY? (2016) (0)
- BODY MASS INDEX AND COMORBIDITIES DO NOT AFFECT ERECTILE FUNCTION OR URINARY CONTINENCE RECOVERY AFTER BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY (2008) (0)
- 530 The effect of time elapsed from surgery on the subsequent risk of cancer specific mortality in renal cell carcinoma patients (2016) (0)
- The number of positive mpMRI-targeted cores is linearly associated with the risk of multifocal clinically significant prostate cancer: Implications for correct patient staging and counselling (2018) (0)
- MP63-04 CLINICAL AND PATHOLOGICAL LYMPH NODE PROGRESSION IN PATIENTS WITH A CT1-T2 N0 M0 RENAL MASS: SHALL WE FOREVER DISCARD THE USE OF LYMPH NODE DISSECTION IN LOW RISK PATIENTS? (2015) (0)
- SAT-092 THE DUEL OF DAVID AND GOLIATH: HOW SHOULD MGFR BEAT THE ESTIMATED GFR? (2020) (0)
- MP56-02 HEAD TO HEAD COMPARISON OF CONDITIONAL ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER (2015) (0)
- The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma (2022) (0)
- Outcomes of laparoscopic and robotic surgery for clinical T2 renal masses in obese patients: A multicenter international study (2018) (0)
- MULTICENTER ANALYSIS OF ONCOLOGIC AND RENAL FUNCTIONAL OUTCOMES OF RADICAL AND PARTIAL NEPHRECTOMY IN STAGE II RENAL CELL CARCINOMA: MP59‐20 (2017) (0)
- 678 External beam radiotherapy with or without androgen deprivation therapy in very elderly patients with high metastatic risk prostate cancer (2016) (0)
- PD15-08 WHEN TO DE-INTENSIFY ONCOLOGIC SURVEILLANCE SCHEME FOR NON-CLEAR CELL RENAL CELL CARCINOMA (2022) (0)
- Surgical and perioperative outcomes after robotic tumor enucleation vs non-enucleative techniques for localized renal masses: Results of a multicenter prospective study from the surface-intermediate-base (SIB) margin score international consortium (2018) (0)
- MP83-17 IMPACT OF INTRA-OPERATIVE TRANSFUSION ON SURVIVAL OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY (2015) (0)
- Retroperitoneal vs. transperitoneal robotic partial nephrectomy for postero-lateral renal masses: An international multicenter analysis (2021) (0)
- 1793 AGE AND AGGRESSIVE PROSTATE CANCER IN PATIENTS WITH LOW RISK CHARACTERISTICS. IMPLICATIONS FOR CONSERVATIVE MANAGEMENT (2011) (0)
- Baseline and post-operative renal function are related to cancer-specific mortality in renal cell carcinoma: Retrospective analysis of a multicentre dataset of 3,500 cases (2018) (0)
- MP36-10 CHEST FOLLOW-UP SCHEDULE OF SURGICALLY RESECTED RENAL CELL CARCINOMA SHOULD BE DIFFERENTIATED ACCORDING TO HISTOLOGICAL SUBTYPE (2018) (0)
- MP20-18 COMPARISON OF RENAL FUNCTIONAL OUTCOMES OF PARTIAL NEPHRECTOMY VS. ANGIOEMBOLIZATION IN THE TREATMENT OF ANGIOMYOLIPOMA: A MULTICENTER ANALYSIS (2019) (0)
- 1017 Systematic assessment of positive surgical margins features in open vs. robot-assisted radical prostatectomy: Is there a difference? (2015) (0)
- 10 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY AT A SINGLE EUROPEAN INSTITUTION (2009) (0)
- Chronic kidney disease at the time of surgery for renal cancer: How and when is it possible to improve from the baseline renal function? Results from a single tertiary care referral centre (2020) (0)
- Imaging intensity after surgery for clear cell renal cell carcinoma (2022) (0)
- Local treatment of metastasis in metastatic RCC may have a significant survival effect across all risk of recurrence groups (2022) (0)
- Lymphovascular invasion predicts lymph node involvement in patients with renal cell carcinoma (2023) (0)
- PD59-07 NEGLECTED LYMPH NODAL METASTASES IN PATIENTS WITH RENAL CANCER: WHEN TO EXTEND THE ANATOMICAL TEMPLATE OF LYMPH NODE DISSECTION DURING NEPHRECTOMY (2022) (0)
- Off-clamp laparoscopic partial nephrectomy in a hybrid room after tumor embolization versus conventional partial nephrectomy: A propensity score matched pair analysis. (2022) (0)
- 509 Simplified Charlson Comorbidity Index for assessment of perioperative mortality after radical cystectomy (2016) (0)
- Outcome after resection of isolated single- or oligometastatic lymph node metastases at the time of nephrectomy (2020) (0)
- MP37-06 ASSESSMENT OF RISK AND PREDICTORS OF DEVELOPING NEWLY ONSET CHRONIC KIDNEY DISEASE AFTER ROBOTIC PARTIAL NEPHRECTOMY FOR CT1 RENAL MASSES (2019) (0)
- Complications and survival outcomes in cardiopathic renal cancer patients elected for surgical treatment (2018) (0)
- 1975 LONG-TERM ERECTILE FUNCTION OUTCOMES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) (2013) (0)
- Renal tumor biopsy to reduce overtreatment of renal oncocytomas. (2020) (0)
- 695 Impact of stage migration on node positive prostate cancer rate and features: A 20-year, single institution analysis in men treated with extended pelvic lymph node dissection (2013) (0)
- 923 The number of organs affected by distant metastases is an independent predictor of cancer specific survival in renal cell carcinoma patients (2012) (0)
- 524 Preoperative renal artery embolization in renal carcinoma with venous thrombus: Preliminary results of a multicenter study (2016) (0)
- Reply from Authors re: Jens. J. Rassweiler, Marcel Fiedler-Hruza. The Learning Curve for Robot-assisted Partial Nephrectomy: There is Much Beyond a Trifecta. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.022: The Clinical Implications of Surgical Learning Curve Analysis: Can We Optimi (2019) (0)
- Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity (2022) (0)
- 311 Prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma patients treated with nephrectomy and extended lymph node dissection (2015) (0)
- 416 AGE AND AGGRESSIVE PROSTATE CANCER IN PATIENTS WITH LOW RISK CHARACTERISTICS. IMPLICATIONS FOR CONSERVATIVE MANAGEMENT (2011) (0)
- MP68-12 PREDICTING INTRAOPERATIVE COMPLICATIONS AND 30-DAYS MORBIDITY USING MACHINE LEARNING TECHNIQUES FOR PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (2020) (0)
- 682 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS (2010) (0)
- New size cut-off proposed by EAU Renal Cancer Working group better identifies patients who can benefit from local tumor ablation (2023) (0)
- The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training (2023) (0)
- Rebuttal from Authors re: Christian Bolenz, Yair Lotan. Decision Making in the Management of Renal Cell Carcinoma: Can Nomograms Assist? Eur Urol 2009;55:296–8 (2009) (0)
- Deciphering the relationship between pathogenic variants and clinical phenotype in VHL patients: Results from a prospective observational study (2023) (0)
- IMPACT OF INTRAOPERATIVE BLOOD TRANSFUSIONS ON SURVIVAL AFTER SURGERY FOR RENAL CELL CARCINOMA: MP55‐15 (2017) (0)
- Clinical outcomes of patients with renal cell carcinoma and imperative indication to become anephric: Implications for multidisciplinary board evaluation (2022) (0)
- 2111 SERUM SEX STEROIDS DEPICT A NON LINEAR U-SHAPED ASSOCIATION WITH HIGH RISK PROSTATE CANCER AT RADICAL PROSTATECTOMY - IMPLICATIONS FOR INDIVIDUALIZED HORMONAL THERAPY (2012) (0)
- Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses (2022) (0)
- Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group (2023) (0)
- Comparative analysis of functional outcomes of open and minimally invasive partial nephrectomy stratified by tumor complexity: A multi-center study (2020) (0)
- The role of percutaneous renal tumor biopsy in frail patients with indeterminate small renal masses (2022) (0)
- Correction to: Renal histology across the stages of chronic kidney disease (2021) (0)
- MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES (2023) (0)
- PD17-11 ADDED VALUE OF CONCOMITANT SYSTEMATIC BIOPSIES IN PREDICTING UPGRADING IN PATIENTS WITH LOCALIZED PROSTATE CANCER DIAGNOSED BY MRI-TARGETED BIOPSY: IMPLICATIONS FOR TREATMENT SELECTION (2019) (0)
- SP044 ROLE OF CELL DEATH IN NEPHROCALCINOSIS: AN IN VITRO STUDY OF HK-2 CELLS (2018) (0)
- Renal tumor heterogeneity analysis in Von Hippel-Lindau disease using single-cell RNA sequencing (2023) (0)
- PD07-02 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM TO PREDICT FIVE-YEARS SIGNIFICANT CKD UPSTAGING AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY (2023) (0)
- 125 RADICAL RETROPUBIC PROSTATECTOMY IN PATIENTS PREVIOUSLY SUBMITTED TO HOLMIUM LASER ENUCLEATION OF THE PROSTATE FOR BENIGN PROSTATIC ENLARGEMENT: A FEASIBILITY STUDY (2007) (0)
- 1126 THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY (2012) (0)
- MP28-02 COMPARATIVE ANALYSIS OF OUTCOMES OF PAPILLARY TYPE 1 AND TYPE 2 AND CLEAR CELL RENAL CELL CARCINOMA: A MULTI-INSTITUTIONAL STUDY (2018) (0)
- Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma (2023) (0)
- 787 SEMINAL VESICLE PRESERVATION DOES NOT IMPROVE FUNCTIONAL OUTCOME OF PATIENTS TREATED WITH BILATERAL NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY (2011) (0)
- FP094ESTIMATED GLOMERULAR FILTRATION RATE: DO WE MEASURE THE REAL RENAL FUNCTION OR ARE WE STILL GROPING IN THE DARK? (2017) (0)
- Renal functional outcomes at 5 years from radical and partial nephrectomies in normal renal function patients: An untold story of hyperfiltrations (2021) (0)
- MP63-01 A PROPOSAL FOR A NOVEL PERI-OPERATIVE MORTALITY RISK ASSESSMENT TOOL IN CONTEMPORARY PATIENTS TREATED WITH RADICAL CYSTECTOMY (2016) (0)
- MP14-05 ADJUVANT VEGF-TKI INHIBITORS AFTER SURGERY IMPROVES PROGRESSION FREE SURVIVAL (BUT NOT SURVIVAL) IN HIGH-RISK RCC PATIENTS (2021) (0)
- MP45-02 EXTERNAL VALIDATION AND HEAD-TO-HEAD COMPARISON OF ALL THE PROGNOSTIC MODELS RECOMMENDED BY THE EUROPEAN ASSOCIATION OF UROLOGY GUIDELINES TO PREDICT ONCOLOGIC OUTCOMES IN PATIENTS WITH RENAL CELL CARCINOMA (2021) (0)
- SURVIVAL AFTER CYTOREDUCTIVE NEPHRECTOMY VS. NO SURGERY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (2009) (0)
- 345 CHANGING AND UNCHANGING FACE OF HIGH RISK PROSTATE CANCER. RESULTS FROM A 15-YEAR, SINGLE INSTITUTION SERIES (2013) (0)
- MP35-18 NEUTROPHIL TO LYMPHOCYTE RATIO IS ASSOCIATED WITH LYMPH NODE INVASION AND HIGHER NODAL BURDEN IN CONTEMPORARY HIGH RISK PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION (2018) (0)
- HP-03-003 The impact of renal cancer diagnosis and planned treatment (radical vs partial nephrectomy) over sexual and mental health (2016) (0)
- 1557 ROLE OF POSITIVE SURGICAL MARGINS IN PATIENTS WITH ORGAN CONFINED PROSTATE CANCER. IMPLICATIONS FOR ADJUVANT TREATMENTS (2010) (0)
- MP48-19 ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN MINIMALLY INVASIVE APPROACH FOR KIDNEY CANCER WITH VENOUS THROMBUS: A MULTICENTRIC STUDY. (2018) (0)
- 323 INTERNATIONAL VALIDATION OF THE PROGNOSTIC VALUE OF LYMPHOVASCULAR INVASION IN RADICAL CYSTECTOMY PATIENTS (2010) (0)
- Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015. (2022) (0)
- 963 PREDICTION OF 30-DAY MORTALITY AFTER CHANNEL TRANSURETHRAL RESECTION FOR PROSTATE CANCER (2009) (0)
- 907 OUTCOME OF PATIENTS POTENTIALLY SUITABLE FOR ACTIVE SURVEILLANCE UNDERGOING RADICAL PROSTATECTOMY AS FIRST TREATMENT CHOICE. RESULTS OF INTERMEDIATE-TERM FOLLOW-UP (2010) (0)
- Patient perspective on serving on the steering committee of the AURORAX-0087A trial for non-metastatic clear cell renal cell carcinoma (2021) (0)
- Outcomes of partial versus radical nephrectomy in octogenarian patients: Results from the resurge project (2018) (0)
- Propensity score matched comparison of minimally invasive partial and radical nephrectomy for clinical T2a renal mass: Analysis of the robotic surgery for large renal mass (ROSULA) group (2019) (0)
- 865 PATHOLOGICAL GLEASON SCORE DICTATES SURVIVAL IN PATIENTS WITH PT3B PCA TREATED WITH RP AND ADJUVANT RT. RESULTS FROM TWO-INSTITUTION SERIES ANALYSIS (2010) (0)
- MP55-09 ASSOCIATION OF AN IMMUNE-GENE SIGNATURE WITH PATHOLOGIC RESPONSE AND OUTCOME AFTER NEOADJUVANT PEMBROLIZUMAB (PEMBRO), COMPARED TO NEOADJUVANT CHEMOTHERAPY (NAC), IN MUSCLE-INVASIVE BLADDER CANCER (MIBC) (2020) (0)
- Long-distance Robot-assisted Teleoperation: Every Millisecond Counts. (2022) (0)
- Trifecta outcomes after percutaneous renal mass ablation: a multicenters analysis (2020) (0)
- 247 SPATIAL DISTRIBUTION OF POSITIVE CORES DECREASES MISCLASSIFICATION RATES OF PATIENTS WITH LOW RISK PROSTATE CANCER CANDIDATE FOR ACTIVE SURVEILLANCE (2013) (0)
- PD57-09 SYSTEMATIC REVIEW AND META-ANALYSIS OF ADJUVANT THERAPY AFTER NEPHRECTOMY FOR HIGH-RISK, NON-METASTATIC RENAL CELL CARCINOMA (2018) (0)
- 724 Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma (2015) (0)
- Recurrence pattern in localized RCC: results from a European multicenter database (RECUR). (2022) (0)
- P0249ESSFSFDSVXVXCVXVVVVDVDDDCVVV (2020) (0)
- FP092 NOVEL ROLE OF IL-20 CYTOKINE SUBFAMILY IN THE PATHOGENESIS OF CHRONIC KIDNEY DISEASES (2018) (0)
- The healthier the patient, the longer the ischemia: Surgical implications for partial nephrectomy in the RECORd2 project (2020) (0)
- Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence. (2022) (0)
- 538 AGE IS AN IMPORTANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENT WITH TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY (2009) (0)
- MP50-03 SYSTEMATIC DEFINITION OF TREATMENT MODALITY AND CLINICAL OUTCOMES REPORTING SYSTEM IN CASE OF SURGICAL TREATMENT FOR VON HIPPEL-LINDAU RENAL CELL CARCINOMA (2022) (0)
- 529 CANCER SPECIFIC OUTCOMES OF PATIENTS WITH GLEASON 8-10 AT RADICAL PROSTATECTOMY: RESULTS OF A SINGLE-INSTITUTION SERIES (2009) (0)
- The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database (2023) (0)
- 1561 NO RESIDUAL TUMOR (PT0) AT RADICAL PROSTATECTOMY IN CLINICAL T1A-B PROSTATE CANCER. DEVELOPMENT OF A NOVEL AND USER-FRIENDLY PREDICTING TOOL (2010) (0)
- MP59-20 COMPARATIVE ANALYSIS OF MINIMALLY INVASIVE RADICAL AND PARTIAL NEPHRECTOMY FOR CLINICAL T2 RENAL MASS: ANALYSIS OF THE ROBOTIC SURGERY FOR LARGE RENAL MASS (ROSULA) GROUP (2018) (0)
- A Comparative Survival Analysis of Nonbilharzial Squamous Cell Carcinoma vs. Transitional Cell Carcinoma After Radical Cystectomy (2009) (0)
- MP63-19 ADEQUATE VS INADEQUATE BCG INTRAVESICAL THERAPY IN INTERMEDIATE AND HIGH RISK NMIBC: TOTAL NUMBER OF INSTILLATIONS IS WHAT REALLY MATTERS (2023) (0)
- Development and internal validation of a nomogram to predict five-years significant CKD upstaging after robot-assisted partial nephrectomy (2023) (0)
- PD07-11 PARTIAL VERSUS RADICAL NEPHRECTOMY FOR COMPLEX RENAL MASS: MULTICENTER COMPARATIVE ANALYSIS OF FUNCTIONAL OUTCOMES (ROSULA COLLABORATIVE GROUP) (2023) (0)
- 903 CHARLSON COMORBIDITY INDEX IS NOT AN INDEPENDENT PREDICTOR OF OVERALL SURVIVAL IN PATIENTS WITH INTERMEDIATE AND HIGH RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY (2011) (0)
- 907 THE NUMBER OF POSITIVE SECTION MARGINS IN HIGH-RISK PROSTATE CANCER IS A POWERFUL AND INDEPENDENT PREDICTOR OF CANCER-SPECIFIC AND OVERALL SURVIVAL IN HIGH-RISK LOCALIZED PROSTATE CANCER (2011) (0)
- MP21-20 THE IMPACT OF ISCHEMIA ON CHRONIC KIDNEY DISEASE PROGRESSION AFTER ROBOTIC PARTIAL NEPHRECTOMY IN PATIENTS OVER 75 YEARS OLD: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES (ROSULA) (2020) (0)
- MP50-10 RISKS AND BENEFITS OF PARTIAL NEPHRECTOMY WITH LIMITED OR WITHOUT ISCHEMIA TIME (2022) (0)
- Frailty Index in predicting surgical outcomes after partial nephrectomy in patients with renal cell carcinoma (2023) (0)
- Multicenter comparison of outcomes for clinical and pathologic T3a renal cell carcinoma. (2020) (0)
- Precision surgery for Von Hippel-Lindau renal cell carcinoma (2022) (0)
- Toward standardized reporting of resection strategies and resection techniques for partial nephrectomy: Insights from a multicenter prospective study within the Surface-Intermediate-Base (SIB) margin score international consortium (2018) (0)
- Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study (2023) (0)
- Imperative versus elective minimally-invasive partial nephrectomy: Results of a multi-institutional collaborative series (2021) (0)
- 150 Misclassification of micro-focus prostate cancer decreases with the extent of biopsy sampling. Importance of accurate detection (2012) (0)
- 2066 MISCLASSIFICATION OF MICRO-FOCUS PROSTATE CANCER DECREASES WITH THE EXTENT OF BIOPSY SAMPLING. IMPORTANCE OF ACCURATE DETECTION (2012) (0)
- MO165CANCER, KIDNEY AND DIET: THE NUTRITIONAL MANAGEMENT IN ONCO-NEPHROLOGICAL PATIENTS. A SINGLE CENTER EXPERIENCE (2021) (0)
- 1203 WHICH IS THE BEST DEFINITION OF ERECTILE FUNCTION RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY? ANALYSIS OF PATIENT SATISFACTION (2010) (0)
- Clinical, surgical, pathological and follow-up features of kidney cancer in patients with von hippel-lindau syndRoma: novel insights from a large european consortium (2020) (0)
- Surveillance interruption and need for active treatment in Von Hippel-Lindau disease: A prospective study from a multidisciplinary program (2023) (0)
- Non-absorbable clip migration after robot-assisted partial nephrectomy: A rare but challenging complication (2023) (0)
- P1 PROSTATE CANCER: STAGINGWednesday, 18 March, 12.45-14.15, Room A315 PATIENTS WITH ORGAN CONFINED PROSTATE CANCER AND POSITIVE SURGICAL MARGINS HAVE SIMILAR RECURRENCE RATES COMPARED TO PATIENTS WITH EXTRA-CAPSULAR EXTENSION AND NEGATIVE SURGICAL MARGINS. A PLEA FOR STAGE RE-CLASSIFICATION (2009) (0)
- 264 EXTENDED LYMPHADENECTOMY INCREASES SURVIVAL IN T3-T4 RENAL CELL CARCINOMA WITH CLINICAL POSITIVE NODES (2011) (0)
- MP41-14 THE LEARNING CURVE OF RADICAL NEPHRECTOMY FOR KIDNEY CANCER: IMPLICATIONS FOR SURGICAL TRAINING (2021) (0)
- Performance of a new risk assessment tool for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the targeted therapy era: REMARCC score (2020) (0)
- IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- Complete response after treatment with first-line targeted anti-vascular endothelial growth factor therapy in metastatic renal cancer: what next? (2016) (0)
- 1041 Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for selection of active surveillance candidates (2015) (0)
- Predictors for perioperative complications in cytoreductive nephrectomy: Analysis of the registry for metastatic RCC (REMARCC) (2020) (0)
- MP12-06 ONCOLOGIC OUTCOMES IN PATIENTS DIAGNOSED WITH pT3aN0M0 RENAL CELL CANCER ACCORDING TO RENAL VEIN THROMBUS OR FAT INVASION (2022) (0)
- MP56-03 NUMBER OF LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY FOR NODE NEGATIVE PROSTATE CANCER: A POTENTIAL MARKER OF DISEASE PERSISTENCE IN PATIENTS WITH EARLY BIOCHEMICAL FAILURE (2015) (0)
- Predicting the Risk of Progression in Patients With Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting. (2022) (0)
- SHOULD SEPTA- AND OCTOGENARIAN PATIENTS WITH PROSTATE CANCER BE TREATED WITH RADICAL PROSTATECTOMY? (2009) (0)
- Proposal and validation of a dynamic criterion for patient inclusion in kidney cancer active surveillance protocols (2017) (0)
- P0729AKARDI: A NEW PREDICTIVE MODEL FOR RENAL DECAY AFTER NEPHRECTOMY (2020) (0)
- 870 LYMPHATIC SPREAD OF NODAL METASTASES IN PROSTATE CANCER: A MAPPING SINGLE-INSTITUTION STUDY (2010) (0)
- PD43-11 PREOPERATIVE ERECTILE DYSFUNCTION IS A PROXY OF CHRONIC KIDNEY DISEASE AFTER SURGERY FOR RENAL CELL CARCINOMA - A PILOT STUDY (2019) (0)
- 621 THE NUMBER OF BIOPSY CORES REPRESENTS ONE OF THE FOREMOST PREDICTOR OF CLINICALLY SIGNIFICANT GLEASON SUM UPGRADING IN LOW RISK PROSTATE CANCER PATIENTS (2009) (0)
- Reply by Authors - Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses (2020) (0)
- Abstracts of the 15th International VHL Medical/Research Symposium (2022) (0)
- MP41-16 DECIPHERING THE RELATIONSHIP BETWEEN PATHOGENIC VARIANTS AND CLINICAL PHENOTYPE IN VHL PATIENTS: RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY (2023) (0)
- 431 External validation of a model predicting survival of men with recurrent prostate cancer after radical prostatectomy (2016) (0)
- Proposal for tripartite reclassification of cT1 renal cell carcinoma into cT1a (very low risk), cT1b (low risk), and cT1c (intermediate risk) substages (2019) (0)
- Active Surveillance for Small Renal Masses in elderly patients do not increase overall mortality rates compared to primary intervention: A propensity score weighted analysis (2019) (0)
- When to de-intensify oncologic surveillance scheme for non-clear cell renal cell carcinoma (2022) (0)
- The current role of renal tumour biopsy in the management of patients with suspected renal cancer: a prospective observational study (2020) (0)
- Analysis of CKD progression for purely Off-Clamp and On-Clamp robotic partial nephrectomy for high nephrometry renal masses: Results of a multicentric series (2023) (0)
- Prevalence, disease-free (DFS) and overall (OS) survival of contemporary high-risk renal cell carcinoma (RCC) patients eligible for adjuvant checkpoint inhibitor trials: A RECUR database analysis. (2019) (0)
- Off-clamp laparoscopic partial nephrectomy in a hybrid room after tumor embolization versus conventional laparoscopic approach: A propensity-matched analysis (2019) (0)
- PD41-02 FEASIBILITY OF OMITTING OUTER (CORTICAL) RENORRHAPHY DURING ROBOTIC PARTIAL NEPHRECTOMY - A MULTI-INSTITUTIONAL ANALYSIS (2019) (0)
- Surgery or Frailty: Who is the master in eGFR decline after renal surgery in living donor and renal cancer patients? (2023) (0)
- Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series (2022) (0)
- Reply to Kazutaka Saito's Words of Wisdom re: Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function. Eur Urol. 2016;69:538. (2016) (0)
- 631 WHICH ARE THE PATIENTS AT RISK TO RECUR BEYOND 10 YEARS AFTER RADICAL PROSTATECTOMY (2009) (0)
- 421 Identifying patients at real risk of dying from prostate cancer. A novel risk score for the selection of patients candidate for adjuvant radiation therapy (2012) (0)
- FIRST REPEATED BIOPSY REPRESENTS THE MOST INFORMATIVE PREDICTOR OF PROGRESSION‐FREE SURVIVAL AT 3 YEARS FOLLOW‐UP IN PATIENTS INCLUDED IN AN ACTIVE SURVEILLANCE PROTOCOL FOR LOW‐RISK PROSTATE CANCER: MP77‐16 (2017) (0)
- PD49-05 THE IRON STUDY: INVESTIGATION OF ROBOT-ASSISTED VERSUS OPEN NEPHRON-SPARING SURGERY (2020) (0)
- EXTERNAL VALIDATION OF THE MAYO CLINIC STAGE, SIZE, GRADE, AND NECROSIS SCORE IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS: PD04‐10 (2017) (0)
- The role of histologic subtypes in follow-up scheme of postsurgical kidney cancer patients (2018) (0)
- Dividing pathologically upstaged T3a renal cell carcinoma is associated with improved alignment of outcomes: A call for TMN revision (2018) (0)
- COMPARATIVE ANALYSIS OF RADICAL AND PARTIAL NEPHRECTOMY IN PATIENTS WITH PREOPERATIVE STAGE 2 CHRONIC KIDNEY DISEASE: A MULTICENTER STUDY: MP72‐03 (2017) (0)
- Long-term assessment of mortality patterns after surgical treatment for non-metastatic kidney cancer: A competing risk analysis (2017) (0)
- The impact of histology and type of energy used on oncological outcomes after local tumor ablation of small renal masses (2022) (0)
- Platinum Priority Reply from (2009) (0)
- Validation of the novel risk-class for non-muscle invasive bladder cancer: Comparison of oncological outcomes between very-high risk and high risk patients (2023) (0)
- MP59-02 RENAL FUNCTION IMPAIRMENT AFTER NEPHRON SPARING SURGERY OR RADICAL NEPHRECTOMY IN PATIENTS WITH CLINICAL T1A-T1B RENAL MASS AND NORMAL PREOPERATIVE GLOMERULAR FILTRATION RATES: RESULTS FROM A LARGE MULTI-INSTITUTIONAL STUDY (2014) (0)
- Predictors of positive surgical margins after partial nephrectomy for localized renal masses: Results of a prospective multicentre study (Surface-Intermediate-Base Project) (2019) (0)
- MP45-08 ACTIVE SURVEILLANCE FOR SMALL RENAL MASSES: A PROSPECTIVE NON-RANDOMIZED MULTIINSTITUTIONAL STUDY (NCT03804320) (2021) (0)
- MP63-03 END STAGE RENAL DISEASE AFTER SURGERY IN PATIENTS WITH NORMAL PREOPERATIVE KIDNEY FUNCTION: THE EFFECT OF NEPHRON-SPARING SURGERY IN DELAYING THE ONSET OF THE DISEASE (2015) (0)
- PD27-07 IMPACT OF SURGICAL TECHNIQUE ON THE RISK OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH INTERMEDIATE AND HIGH-RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY (2014) (0)
- 18 IMPACT OF STAGE MIGRATION ON THE PREVALENCE OF PELVIC LYMPH NODE METASTASES IN PATIENTS UNDERGOING EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: A 23-YEAR SINGLE INSTITUTION EXPERIENCE (2009) (0)
- 691 PSA DENSITY DOES NOT IMPROVE THE ABILITY TO PREDICT NON-ORGAN CONFINED AND HIGH GRADE PROSTATE CANCER COMPARED TO PSA IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2009) (0)
- Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial. (2022) (0)
- MP58-15 LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE IDENTIFIES PATIENTS AT HIGH-RISK OF ADVERSE OUTCOMES AFTER KIDNEY SURGERY FOR RENAL CANCER: A PROSPECTIVE CLINICAL STUDY (2023) (0)
- MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE (2020) (0)
- Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localized prostate cancer: A stage-by-stage analysis on the risk of clinical recurrence (2018) (0)
- Active surveillance for small renal masses: a prospective translational study update (NCT03804320) (2020) (0)
- Trifecta outcomes of partial nephrectomy in patients over 75 years old: A multi-institutional study (2018) (0)
- MO425RENAL SURGERY APPROACHES AND POST-OPERATIVE AKI DEVELOPMENT IN NORMAL RENAL FUNCTION PATIENTS; AN HIDDEN TREATH (2021) (0)
- 520 PELVIC LYMPH NODE DISSECTION SHOULD BE OMITTED IN LOW RISK PROSTATE CANCER PATIENTS. RESULTS OF A MATCHED ANALYSIS (2009) (0)
- 663 ADJUVANT RADIOTHERAPY NEGATIVELY IMPACTS ON THE LONG-TERM RECOVERY OF NORMAL SEXUAL FUNCTION IN TESTICULAR GERM-CELL CANCER SURVIVORS (2012) (0)
- Impact of intraoperative bleeding on the risk of chronic kidney disease after elective nephron sparing surgery in patients with T1b kidney cancer (2019) (0)
- 439 When is tumour volume an exclusion criteria for focal therapy? Results from a radical prostatectomy series (2016) (0)
- Erratum: Age‐adjusted validation of the most stringent criteria for active surveillance in low‐risk prostate cancer patients (2012) (0)
- 686 Association between time to biochemical recurrence and cancer specific and other cause mortality in men with high risk prostate cancer treated with radical prostatectomy without adjuvant treatments. A multi-institutional analysis (2013) (0)
- MP69-18 HOW TO EXPAND INDICATIONS FOR ACTIVE SURVEILLANCE WITHOUT COMPROMISING CANCER CONTROL: A SYSTEMATIC ASSESSMENT OF THE CURRENTLY USED CRITERIA FOR PROSTATE CANCER PATIENTS (2014) (0)
- 357 High risk prostate with pT3-tumor and positive surgical margin – relevance for clinical failure and prostate cancer mortality: Results of a prospective single institution series (2012) (0)
- 618 IDENTIFYING FACTORS AFFECTING RENAL FUNCTION IN PATIENTS WITH PT1B RENAL CELL CARCINOMA WHO UNDERWENT RADICAL OR PARTIAL NEPHRECTOMY (2011) (0)
- 84 DOES ORGASM ASSOCIATED INCONTINENCE (CLIMACTURIA) IMPACT ON ORGASMIC FUNCTION IN MEN SUBMITTED TO BILATERAL NERVE SPARING OPEN RADICAL PROSTATECTOMY (2010) (0)
- Molecular characterization of residual bladder cancer after pembrolizumab (2021) (0)
- ERECTILE FUNCTION OUTCOME OF UNTREATED PATIENTS AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2009) (0)
- MP58-19 DETECTION OF PULMONARY LESION DURING FOLLOW-UP AFTER SURGERY FOR LOCALIZED RENAL CELL CARCINOMA: DISEASE PROGRESSION OR A PRIMARY LUNG CANCER? (2023) (0)
- 942 Perioperative outcome and oncological follow up in a large series of patients with renal cell carcinoma invading supradiaphragmatic vena cava and treated with nephrectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest (2014) (0)
- MP73-05 WHEN TO PERFORM A STAGING CHEST-CT SCAN BEFORE SURGICAL TREATMENT FOR KIDNEY CANCER (2016) (0)
- Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006. (2022) (0)
- 473 Pathological nodal staging score for prostate cancer: A tool to address adequate nodal dissection in men treated with radical prostatectomy (2013) (0)
- Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registry (2020) (0)
- 1928 ASSOCIATION BETWEEN THE NUMBER OF CORES TAKEN AT INITIAL PROSTATE BIOPSY AND INSIGNIFICANT PROSTATE CANCER AT RADICAL PROSTATECTOMY IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE. NEED FOR ACCURATE BIOPSY SAMPLING (2013) (0)
- 827 IS THE REGION OF PELVIC LYMPH NODE DISSECTION ASSOCIATED WITH LYMPHORRHEA AFTER RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION (2010) (0)
- Prognostic differences and survival outcomes in patients with papillary renal cell carcinoma subtypes – a comparison between type I VS. type II (2020) (0)
- Haemospermia in the real- life setting: a new high-risk stratification. (2021) (0)
- Papillary renal cell carcinoma type I and II: Two distinct diseases with different clinical and therapeutical implications (2021) (0)
- PD07-02 DIVIDING PATHOLOGICALLY UPSTAGED T3A RENAL CELL CARCINOMA BASED ON CLINICAL T STAGE AT PRESENTATION IS ASSOCIATED WITH IMPROVED ALIGNMENT OF OUTCOMES: A CALL FOR TNM REVISION (2019) (0)
- MP45-11 WHICH CLINICAL CHARACTERISTICS SHOULD PROMPT MULTIDISCIPLINARY TEAM EVALUATION AFTER DIAGNOSING NON-METASTATIC RENAL CELL CARCINOMA: IMPLICATIONS FOR PATIENT REFERRAL, PRE-SURGICAL TRIALS AND HEALTH CARE POLICIES (2021) (0)
- MP49-18 PRE-OPERATIVE RISK CALCULATOR OF THE PROBABILITY OF COMPLETING NEPHRON-SPARING SURGERY FOR KIDNEY CANCER: THE KEY ROLE OF TUMOR COMPLEXITY AND APPROACH (2021) (0)
- Radical prostatectomy for stage T1a-T1b prostate cancer: Analysis of predictors for residual disease and biochemical recurrence (2008) (0)
- Frailty status predicts worse postoperative outcomes and long-term oncologic outcomes in patients treated with partial nephrectomy (2022) (0)
- Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians (2022) (0)
- Impact of pre-existing diabetes mellitus on survival in stage I renal cell carcinoma. (2018) (0)
- MP40-19 HOW TO IDENTIFY PATIENTS SUITABLE FOR CONSERVATIVE MANAGEMENT OF UPPER TRACT UROTHELIAL CARCINOMA (UTUC) ACCORDING TO TUMOR SIZE: IMPLICATIONS FOR CLINICAL GUIDELINES (2022) (0)
- What are the predictors of oncocytoma histology at pathological analysis after partial nephrectomy for small renal masses? Insights from a large prospective multicentre study (RECORd2 project) (2020) (0)
- Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC). (2020) (0)
- POST‐OPERATIVE COMPLICATIONS INCREASE THE RISK OF CHRONIC KIDNEY DISEASE AFTER ELECTIVE NEPHRON SPARING SURGERY: MP59‐07 (2017) (0)
- CAN WE PREDICT PROLONGED LYMPHORRHEA IN PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY AND PELVIC LYMPHADENECTOMY (2008) (0)
- SP267RENAL HISTOLOGY VERSUS ESTIMATED GLOMERULAR FILTRATION RATE: BEYOND THE LOOKING GLASS (2019) (0)
- PD56-02 THE DETRIMENTAL EFFECT OF FRAILTY STATUS ON RENAL FUNCTION RECOVERY AFTER PARTIAL NEPHRECTOMY – LONG-TERM RESULTS FROM A PROSPECTIVE SURGICAL COHORT (2022) (0)
- Estimated glomerular filtration rate: Do we measure the real renal function or are we still groping in the dark? (2018) (0)
- Editorial Comment from Dr Martini et al. to Independent external validation of a nomogram to define risk categories for a significant decline in estimated glomerular filtration rate after robotic‐assisted partial nephrectomy (2020) (0)
- The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial (NCT03955393) (2020) (0)
- MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY (2019) (0)
- 127. A quantitative EMG analysis of the external urethral sphincter in continent males with prostatic pathology (2013) (0)
- External validation of the VHL alliance guidelines for VHL genetic testing in patients diagnosed with renal cell carcionoma (2021) (0)
- POD-07.02 Positive Surgical Margin at Bladder Neck Is an Independant Predictor of Local Failure and Prostate Cancer Mortality in pT3-Prostate Cancer. Results of a Prospective Single Institution Series (2011) (0)
- Glycosaminoglycan (GAG) scores for surveillance of recurrence in Leibovich Points ≥5 non-metastatic clear cell renal cell carcinoma: AURORAX-0087A trial in progress report (2020) (0)
- MP47-09 THE ADDED VALUE OF HISTOLOGICAL SUBTYPE IN THE PREDICTION OF ONCOLOGIC OUTCOMES IN PATIENTS WITH NON-METASTATIC PAPILLARY RENAL CELL CARCINOMA (2022) (0)
- 640 Head-to-head comparison of conditional oncological outcomes after radical prostatectomy in patients with intermediate and high risk prostate cancer (2015) (0)
- Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (2020) (0)
- First-line treatment in advanced renal cell carcinoma: A quasi-individual patient data meta-analysis (2022) (0)
- 977 Nephron sparing surgery decreases other-causes mortality relative to radical nephrectomy only in specific subgroups of patients with renal cell carcinoma (2016) (0)
- NEPHRON SPARING TECHNIQUES INDEPENDENTLY REDUCE THE RISK OF CARDIOVASCULAR EVENTS AFTER SURGERY IN PATIENTS WITH A SMALL RENAL MASS AND A NORMAL PREOPERATIVE RENAL FUNCTION (2014) (0)
- Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy (2022) (0)
- 466: Age is an Independent Predictor of Bone Metastasis at Prostate Cancer Diagnosis (2007) (0)
- Comparison of robot-assisted and open surgery partial nephrectomy: an observational prospective study on functional and oncologic outcomes (2017) (0)
- 776 ASSOCIATION BETWEEN TIME TO BIOCHEMICAL RECURRENCE AND CANCER SPECIFIC AND OTHER CAUSE MORTALITY IN MEN WITH HIGH RISK PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY WITHOUT ADJUVANT TREATMENTS. A MULTI-INSTITUTIONAL ANALYSIS (2013) (0)
- MP24-20 ANALYSIS OF PREDICTORS OF sCKD PROGRESSION AFTER MINIMALLY-INVASIVE IMPERATIVE PARTIAL NEPHRECTOMY IN PATIENTS WITH PREOPERATIVE CKD STAGE 3A: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES (2022) (0)
- 714 Spatial distribution of positive cores decreases misclassification rates of patients with low risk prostate cancer candidate for active surveillance (2013) (0)
- MP56-16 VERY LONG TERM OUTCOMES OF RADICAL PROSTATECTOMY IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER. RESULTS FROM A SINGLE INSTITUTION SERIES (2015) (0)
- The impact of surgical strategy in robot-assisted partial nephrectomy: Should we treat anterior tumours with transperitoneal access and posterior tumours with retroperitoneal access? (2018) (0)
- Clinical, surgical, pathological and follow-up features of kidney cancer in patients with Von Hippel-Lindau syndrome: Novel insights from a large European consortium (2020) (0)
- 686 Reductive cystoplasty and simultaneous prostatic adenomectomy improve symptoms score in patients with chronic obstructive urine retention and detrusor impaired contractility (2014) (0)
- Robot-assisted partial nephrectomy versus percutaneous thermal ablation for renal mass in solitary kidney: a multicenter analysis (2022) (0)
- 780 Models assessing the need for pelvic lymph node dissection cannot be reliably used in men with prostate cancer previously treated with surgery for benign prostatic enlargement (2012) (0)
- Penile Rehabilitation After Robotic Radical Prostatectomy: The Best Strategy (2011) (0)
- PD46-06 UROLOGICAL FOLLOW-UP AND MUTATIONAL PATTERNS IN LYNCH SYNDROME PATIENTS: A SINGLE CENTER EXPERIENCE (2023) (0)
- Prognostic differences in patients with T1a renal cell carcinoma according to clinical size (2020) (0)
- ERECTILE DYSFUNCTION Is Erectile Dysfunction a Reliable Proxy of General Male Health Status ? The Case for the International Index of Erectile Function — Erectile (2010) (0)
- European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View. (2022) (0)
- 1035 FACTORS PREDICTING PATHOLOGICAL STAGE IN PATIENTS SUBMITTED TO RADICAL RETROPUBIC PROSTATECTOMY DUE TO INCIDENTAL (T1A-T1B) PROSTATE CANCER (2007) (0)
- MP68-02 COMPARATIVE ANALYSIS OF FUNCTIONAL OUTCOMES OF OPEN AND MINIMALLY INVASIVE PARTIAL NEPHRECTOMY STRATIFIED BY TUMOR COMPLEXITY (2020) (0)
- MP42-16 IMPACT OF PRE-EXSISTING DIABETES MELLITUS ON SURVIVAL IN STAGE I RENAL CELL CARCINOMA (2018) (0)
- Concordance of pathologic outcomes in patients with synchronous bilateral renal masses elected for surgical treatment: Implications for preoperative renal biopsy (2020) (0)
- MP08-14 LONG TERM OUTCOMES OF REPEATED MITOMYCIN C INSTILLATION IN LOW RISK AND INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS (2023) (0)
- 502 EXTERNAL VALIDATION OF THE MOST ACCURATE NOMOGRAM CANCER SPECIFIC MORTALITY IN RENAL CELL CARCINOMA (2011) (0)
- MP34-14 WHICH PATIENTS WITH CLINICALLY NODE POSITIVE PROSTATE CANCER BENEFIT FROM RADICAL PROSTATECTOMY? THE IMPACT OF THE SIZE AND SITE OF NODAL INVOLVEMENT (2018) (0)
- 1002 The 2011 national comprehensive cancer network guidelines recommendations for pelvic lymph node dissection in prostate cancer patients are not accurate. A plea for renewal (2012) (0)
- Robot-assisted partial nephrectomy versus percutaneous ablation for completely endophytic renal masses: a multicenter analysis with a minimum 3-year follow-up (2022) (0)
- The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma (2022) (0)
- PD11-05 MULTICENTER COMPARISON OF OUTCOMES FOR CLINICAL AND PATHOLOGIC T3A RENAL CELL CARCINOMA (2020) (0)
- PD51-02 PLANNED SECONDARY ANALYSIS OF PURE-01 (2020) (0)
- Laparoscopic versus robotic partial nephrectomy in obese patients: Perioperative and early functional outcomes from a large contemporary series (RECORD2 project) (2022) (0)
- Multicenter comparison of outcomes for clinical and pathologic T3a renal cell carcinoma (2020) (0)
- 768 DO NODAL METASTASES INVARIABLY IMPACT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER? IMPORTANCE OF LOCAL DISEASE STATUS (2012) (0)
- PD49-08 HYPERTENSION AND CARDIOVASCULAR MORBIDITY FOLLOWING RADICAL NEPHRECTOMY ARE ONLY SUSTAINED BY RENAL PARENCHYMA LOSS AND CARDIOVASCULAR MORBIDITY (2020) (0)
- Impact of benign histology on perioperative complication and functional outcomes of robot assisted partial nephrectomy (2023) (0)
- 771 IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION (2013) (0)
- Impact of resection techniques on perioperative and early functional outcomes after partial nephrectomy for localized renal masses: Results from a prospective, multicentre study (SIB Project) (2019) (0)
- Multicenter analysis of oncologic and renal functional outcomes of radical and partial nephrectomy in stage II renal cell carcinoma (2017) (0)
- The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series (2020) (0)
- PATHOLOGICAL FINDINGS AT RADICAL PROSTATECTOMY AFTER INITIAL ACTIVE SURVEILLANCE IN LOW‐RISK PROSTATE CANCER PATIENTS. DID WE MISS THE CHANCE TO CURE?: PD51‐11 (2017) (0)
- WHEN TO PERFORM PREOPERATIVE BONE SCINTIGRAPHY FOR KIDNEY CANCER STAGING: PD52‐05 (2017) (0)
- Perioperative morbidity of open, laparoscopic and robotic partial nephrectomy: A prospective multicenter observational study (RECORd2) (2019) (0)
- How to maximize the diagnostic rate of endoscopic biopsy during flexible ureteroscopy for upper tract urothelial carcinoma (2022) (0)
- MO177: The Impact of a Low-Normal Protein High Calorie Diet on the Nephrological Scenario and Perceived Quality of Life of Oncourological Patients with Chronic Kidney Disease (2022) (0)
- Impact of molecular subtyping and immune infiltration on response and outcome following neoadjuvant pembrolizumab (pembro), versus neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (2020) (0)
- Prediction of significant renal function decline after open, laparoscopic and robotic partial nephrectomy: Refinement of the Martini’s nomogram on the RECORD2 project cohort (2022) (0)
- The impact of ischemia on chronic kidney disease progression after robotic partial nephrectomy in patients over 75 years old: Results of a multi-institutional collaborative series (ROSULA) (2020) (0)
- MP58-08 CONCORDANCE OF RENAL SINUS OR CALYCES INVASION BETWEEN PREOPERATIVE IMAGING AND FINAL PATHOLOGY AFTER SURGERY FOR KIDNEY CANCER (2023) (0)
- MO189: The Clinical Relevance of Measured GFR in Patients with Solitary Kidney after Radical Nephrectomy: The Estimation is not Enough (2022) (0)
- 467 Are the effort towards prostate cancer early detection associated with a significant reduction in tumor volume? An analysis stratified according to risk categories (2013) (0)
- Can we modulate the extent of nodal dissection according to the preoperative risk of lymph node invasion in prostate cancer patients undergoing radical prostatectomy (2017) (0)
- SAT-093 THE STRANGE CASE OF RENAL FUNCTION AFTER RADICAL NEPHRECTOMY: A FOGGY FORECAST (2020) (0)
- EAU Robotic Urology Section Host Centres certification: Current status of training in robotic Urology in Europe (2018) (0)
- Is a preoperative low ejection fraction a risk factor for complications and impaired survival in renal cancer patients who undergo surgery? Results from a propensity-score matching with non cardiopathic counterparts (2017) (0)
- MP57-09 COMBINED ASSESSMENT OF LONG-TERM FUNCTIONAL AND ONCOLOGIC OUTCOMES AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY: THE ROME'S SCORE (2020) (0)
- Refining the indication for adjuvant pembrolizumab in patients with clear cell renal cell carcinoma at high risk of recurrence using a risk-adapted approach: A contemporary multicentre study (2023) (0)
- 668 A COMPARATIVE SURVIVAL ANALYSIS OF ADENOCARCINOMA VS. TRANSITIONAL CELL CARCINOMA AFTER RADICAL CYSTECTOMY (2009) (0)
- DEVELOPMENT OF PROGNOSTIC MODELS FOR INDIVIDUAL RISK STRATIFICATION IN PATIENTS TREATED WITH RADICAL NEPHROURETERECTOMY: A NEW TOOL TO HELP WITH PATIENT SELECTION FOR ADJUVANT THERAPY (2009) (0)
- 35 How to expand indications for active surveillance without compromising cancer control: A systematic assessment of the currently used criteria for prostate cancer patients (2014) (0)
- DOES PROSTATE CANCER REPRESENT THE MAIN CAUSE OF DEATH IN ALL NODE POSITIVE PROSTATE CANCER PATIENTS? THE IMPACT OF COMPETING CAUSES OF MORTALITY ACCORDING TO TUMOR CHARACTERISTICS AND RECURRENCE STATUS: PD03‐03 (2017) (0)
- Should stage III renal cell carcinoma with pN1 be classified as stage IV of the American Joint Committee on Cancer classification? A RECUR external validation (2019) (0)
- PD60-12 THE IMPACT OF FRAILTY STATUS ON SURGICAL OUTCOMES AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY - A PROSPECTIVE ASSESSMENT USING A STANDARDIZED COLLECTION SYSTEM FOR PERIOPERATIVE OUTCOMES (2022) (0)
- Is pathological upstaging to T3a renal cell carcinoma associated with a similar prognosis to non-upstaged pathologic T3a disease? A multicenter analysis. (2023) (0)
- MO155: The Importance of Measured GFR in Clinical Practice: An Old Knowledge for Nephrologists, a New Challenge for Oncologists and Surgeons (2022) (0)
- A patient tailored follow-up protocol for men with prostate cancer managed with active surveillance with the use of multiparametric magnetic resonance imaging: Identifying predictors of early and late reclassification in a large single institution cohort (2023) (0)
- 3D virtual models improve the accuracy of nephrometric scores in predicting surgical complexity during robotic partial nephrectomy: Results of a collaborative ERUS validation study (2023) (0)
- 743 CONCORDANCE BETWEEN CLINICAL AND PATHOLOGICAL LYMPH NODE INVASION IN RENAL CELL CARCINOMA (2013) (0)
- MP58-05 THE IMPACT OF HISTOLOGY AND TYPE OF ENERGY USED ON ONCOLOGICAL OUTCOMES AFTER LOCAL TUMOR ABLATION OF SMALL RENAL MASSES (2023) (0)
- MP14-07 RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY (2019) (0)
- Detection of pulmonary lesion during follow-up after surgery for localized renal cell carcinoma: Disease progression or a primary lung cancer? (2023) (0)
- 936 Has the new edition of the TNM improved the lymph node staging for renal cell carcinoma (2014) (0)
- 1046 THREE OR MORE POSITIVE NODES AT RADICAL PROSTATECTOMY REPRESENT A SIGNIFICANT CUT-OFF VALUE FOR CSS IN HIGH-RISK PROSTATE CANCER, WHILE 1 OR 2 POSITIVE NODES DO NOT INFLUENCE CSS (2011) (0)
- Predicting intraoperative complications and 30-days morbidity using machine learning techniques for patients undergoing robotic partial nephrectomy (RPN) (2020) (0)
- Patterns and predictors of resection techniques during partial nephrectomy for T1 renal masses: Results of a multicentre prospective cohort study from the surface-intermediate-base (SIB) margin score international consortium (IDEAL phase 2b) (2018) (0)
- 723 ADJUVANT RADIOTHERAPY REDUCES THE RATE OF URINARY CONTINENCE RECOVERY AFTER RADICAL PROSTATECTOMY IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS (2011) (0)
- The ability of three comorbity indeces to predict postosperative mortality in renal cell carcinoma patients: The impending need of a new disease-specific index (2017) (0)
- MP57-14 PROSTATE BIOPSY CENTRALIZATION AT HIGH VOLUME, TERTIARY CARE CENTERS REPRESENTS THE MOST REFINED DIAGNOSTIC TOOL FOR PROSTATE CANCER PATIENTS: RESULTS FROM A PROSPECTIVE SERIES (2018) (0)
- PREDICTIVE FACTORS OF RESECTION TECHNIQUES DURING PARTIAL NEPHRECTOMY IN A COHORT OF “ENUCLEORESECTIVE” CENTERS: INSIGHTS FROM THE SURFACE–INTERMEDIATE–BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM (2016) (0)
- Systematic review and meta-analysis of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma (2018) (0)
- 982 STAGING LYMPHADENECTOMY IN RENAL CELL CARCINOMA MUST BE EXTENDED: A SENSITIVITY CURVE ANALYSES (2012) (0)
- PD28-06 SURVIVAL OUTCOMES IN OCTOGENARIAN AND NONAGENARIAN PATIENTS TREATED WITH FIRST-LINE ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER (2016) (0)
- PROPOSAL AND VALIDATION OF A DYNAMIC CRITERION FOR PATIENT INCLUSION IN KIDNEY CANCER ACTIVE SURVEILLANCE PROTOCOLS: PD59‐08 (2017) (0)
- PREOPERATIVE HAEMATOLOGICAL PARAMETERS AS PREDICTORS OF LONG‐TERM SURVIVAL IN RENAL CELL CARCINOMA: MP22‐14 (2017) (0)
- Assessing the role of frailty status on surgical, oncologic and functional outcomes in patients treated with robot-assisted radical prostatectomy for prostate cancer (2022) (0)
- Is robotic transperitoneal partial nephrectomy safe in the management of cystic renal cell masses? Outcomes of an ERUS multicenter study including 216 patients (2021) (0)
- 770 A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS (2012) (0)
- Impact of neoadjuvant immune-checkpoint inhibitor on intra and post operative outcomes in patients with muscle-invasive bladder cancer treated with radical cystectomy (2023) (0)
- What are the predictors of oncocytoma histology at pathological analysis after partial nephrectomy for small renal masses? insights from a large prospective multicentre study (record 2 project) (2020) (0)
- Frailty status predicts worse postoperative and long-term oncologic outcomes in patients treated with partial nephrectomy for small renal masses (2022) (0)
- WHICH ARE THE PATIENTS AT RISK TO RECUR BEYOND 10 YEARS AFTER RADICAL PROSTATECTOMY (2009) (0)
- Partial versus radical nephrectomy in patients with renal cell carcinoma and renal or caval thrombus: Oncological and functional outcomes from an individual matched cohort analysis (2017) (0)
- Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of clinical tumour size on postoperative renal function (2020) (0)
- PD64-11 ROBOTIC PARTIAL NEPHRECTOMY VS. MINIMALLY INVASIVE RADICAL NEPHRECTOMY FOR CLINICAL T3A RENAL MASS: ANALYSIS FROM THE ROSULA (ROBOTIC SURGERY FOR LARGE RENAL MASS) COLLABORATIVE GROUP (2021) (0)
- PD59-04 APPLICATION OF THE KEYNOTE-564 TRIAL RESULTS TO REAL LIFE POPULATION: WHICH PATIENTS WITH ADVANCED KIDNEY CANCER SHOULD RECEIVE ADJUVANT PEMBROLIZUMAB (2022) (0)
- PD32-09 VERY LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR NODE POSITIVE PROSTATE CANCER: A MULTI-INSTITUTIONAL, CONDITIONAL SURVIVAL ANALYSIS (2015) (0)
- 917 WHAT IS THE AGE LIMIT FOR RADICAL THERAPY IN PROSTATE CANCER PATIENTS? ANALYSIS ON PATIENT SURVIVAL (2010) (0)
- Laparoscopic versus robot-assisted partial nephrectomy for cT1 renal tumors in obese patients: Analysis of perioperative and follow-up functional outcomes (the RECORd2 project) (2023) (0)
- The risk of Von Hippel-Lindau disease according to individual sporadic cancer in a multidisciplinary program: External validation of the VHL Alliance guidelines for genetic referral (2022) (0)
- PD07-03 UNVEIL THE INTERPLAY BETWEEN BASELINE RENAL FUNCTION, WARM ISCHEMIA TIME AND TUMOR COMPLEXITY WHEN ASSESSING RENAL FUNCTIONAL OUTCOMES OF ON- VS OFF-CLAMP ROBOT-ASSISTED PARTIAL NEPHRECTOMY (2023) (0)
- 373 PATHOLOGICAL NODAL STAGING SCORE FOR PROSTATE CANCER: A TOOL TO ADDRESS ADEQUATE NODAL DISSECTION IN MEN TREATED WITH RADICAL PROSTATECTOMY (2013) (0)
- Minimally invasive partial nephrectomy in the elderly patient: Analysis from the resurge collaborative project (2018) (0)
- PD12-07 PREOPERATIVE FRAILTY PREDICTS ADVERSE SHORT-TERM POST-OPERATIVE OUTCOMES IN PATIENTS TREATED WITH PARTIAL NEPHRECTOMY (2021) (0)
- Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma (2022) (0)
- Perioperative and mid-term oncological and functional outcomes after partial nephrectomy for entirely endophytic renal tumors: A prospective multicenter observational study (the RECORD2 Project) (2021) (0)
- Perioperative complications after partial nephrectomy for complex renal tumors: A prospective multicenter observational study (RECORd 2 project) (2019) (0)
- 609 Are all pathologic Gleason scores 8 created equal? Implications for the applicability of new prostate cancer grading system (2016) (0)
- MP37-12 CLINICAL AND SURGICAL PREDICTORS OF MEDICAL AND SURGICAL POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH LIMITED LIFE EXPECTANCY TREATED WITH PARTIAL NEPHRECTOMY FOR RENAL TUMORS: INSIGHT FROM THE RECORD 2 PROJECT (2019) (0)
- V5 Robot-assisted adrenalectomy in case of bulky pheochromocytoma (2016) (0)
- MP58-14 FRAILTY INDEX IN PREDICTING SURGICAL OUTCOMES AFTER PARTIAL NEPHRECTOMY IN PATIENTS WITH RENAL CELL CARCINOMA (2023) (0)
- 644 Very long term outcomes of radical prostatectomy in patients with clinically localized prostate cancer. Results from a single institution series (2015) (0)
- 83 IDENTIFYING THE BEST CANDIDATES FOR PENILE PHARMACOLOGICAL REHABILITATION AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY (2010) (0)
- PD-0462: Post-prostatectomy WPRT does not increase the risk of second cancers: A single institution analysis of 953 patients (2013) (0)
- Partial nephrectomy in frail patients: Effect of surgical approach on complications and health-care expenditures (2021) (0)
- Preoperative erectile dysfunction is a proxy of chronic kidney disease after surgery for renal cell carcinoma – a pilot study (2019) (0)
- MP62-05 SYSTEMATIC ASSESSMENT OF POSITIVE SURGICAL MARGINS FEATURES IN OPEN VS. ROBOT ASSISTED RADICAL PROSTATECTOMY: IS THERE A DIFFERENCE? (2015) (0)
- Predicting complications after robotic partial nephrectomy: Back to simplicity (2021) (0)
- 365 ROLE OF THE SELECTIVE UPPER URINARY TRACT CYTOLOGY IN PATIENTS WITH SUSPICIOUS TRANSITIONAL LESIONS (2011) (0)
- Incidental prostate cancer (pT1a-pT1b) detection at BPH surgery in the modern era - are we modifying the detection rate? (2017) (0)
- 1474 PT3-PROSTATE CANCER-POSITIVE SURGICAL MARGIN AT BLADDER NECK IS AN INDEPENDANT PREDICTOR OF LOCAL FAILURE AND PROSTATE CANCER MORTALITY: RESULTS OF A PROSPECTIVE SINGLE INSTITUTION SERIES (2011) (0)
- MP26-12 TRIFECTA OUTCOMES OF PARTIAL NEPHRECTOMY IN PATIENTS OVER 75 YEARS OLD: A MULTI-INSTITUTIONAL STUDY: ANALYSIS OF THE RENAL SURGERY IN ELDERLY (RESURGE) GROUP (2018) (0)
- PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK (2022) (0)
- PD24-12 COMPARISON BETWEEN LIVER DEROTATION WITH PRINGLE MANOEUVRE AND CARDIOPULMONARY BYPASS WITH DEEP-HYPOTHERMIC CARDIAC ARREST FOR KIDNEY CANCER WITH MAYO III TUMOR THROMBUS: INTRA-, PERI- AND POSTOPERATIVE OUTCOMES (2018) (0)
- 897 IS 10-YEAR FOLLOW-UP LONG ENOUGH TO EVALUATE ONCOLOGICAL OUTCOMES OF PATIENTS AFTER RADICAL PROSTATECTOMY? IMPORTANCE OF LONG- TERM ASSESSMENT (2011) (0)
- Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis (2022) (0)
- MP59-08 ASSESSING PREDICTORS OF CHRONIC KIDNEY DISEASE PROGRESSION IN PATIENTS RECEIVING MINIMALLY-INVASIVE PARTIAL NEPHRECTOMY: RESULTS OF A MULTI-INSTITUTIONAL COLLABORATIVE SERIES (2021) (0)
- MP68-17 MANAGEMENT OF PATIENTS DIAGNOSED WITH ANGIOMYOLIPOMA ACCORDING TO EAU GUIDELINES: PROFILE OF SURGICAL ADVERSE EVENTS TO AID CLINICAL DECISION MAKING (2020) (0)
- 761 How to expand the indication criteria for active surveillance without compromising cancer control. The importance of the extent of biopsy sampling (2012) (0)
- New-onset chronic kidney disease after surgery for localized renal masses in patients with two kidneys and preserved renal function: A contemporary multicentre study (2023) (0)
- 651 Renal function impairment after nephron sparing surgery or radical nephrectomy in patients with clinical T1a-T1b renal mass and normal preoperative glomerular filtration rates: Results from a large multi-institutional study (2014) (0)
- PD60-11 IMPACT OF THE TIME ELAPSED BETWEEN PROSTATE BIOPSY AND SURGERY ON THE ACCURACY OF THE BRIGANTI NOMOGRAM PREDICTING LYMPH NODE INVASION IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER (2022) (0)
- MP68-03 THE HEALTHIER THE PATIENT, THE LONGER THE ISCHEMIA (2020) (0)
- MP64-08 99mTC- SESTAMIBI SPECT/CT FOR THE CHARACTERIZATION OF SMALL RENAL MASSES: INITIAL EXPERIENCE FROM a TERTIARY REFERRAL CENTER (2023) (0)
- The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery (2020) (0)
- Central prostate biopsy revision at referral center is key for correct patient management: Results from a prospective, single center series (2018) (0)
- 451 Biochemical recurrence after radical prostatectomy: Who is at risk of dying from prostate cancer? (2015) (0)
- Pathological features and predictors of oncologic outcomes in patients with small renal masses (2020) (0)
- LAPAROSCOPIC NEPHROURETERECTOMY DOES NOT UNDERMINE CANCER CONTROL OUTCOMES IN SELECTED PATIENTS WITH NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA (2009) (0)
- Surgical treatment for Von Hippel Lindau renal cell carcinoma: analysis of clinical outcomes from the san raffaele VHL program (2022) (0)
- 841 THE VALUE OF COMPUTED TOMOGRAPHY IN DETECTING PROSTATE CANCER LYMPH NODE METASTASIS IS LIMITED EVEN IN CONTEMPORARY PATIENTS WITH VERY HIGH RISK OF NODAL INVOLVEMENT (2011) (0)
- 185 MODELS ASSESSING THE NEED FOR PELVIC LYMPH NODE DISSECTION CANNOT BE RELIABLY USED IN MEN WITH PROSTATE CANCER PREVIOUSLY TREATED WITH SURGERY FOR BENIGN PROSTATIC ENLARGEMENT (2012) (0)
- What’s the best model to predict eGFR loss at 1 year after minimally invasive partial nephrectomy? (2022) (0)
- Identification of the best candidates for PSMA PET/CT among patients experiencing biochemical recurrence after radical prostatectomy. A new tool to optimize of Patient Selection (2021) (0)
- MP58-12 VENOUS TUMOUR THROMBUS IN RENAL CELL CARCINOMA: LOCALLY ADVANCED OR METASTATIC DISEASE? (2023) (0)
- PATIENTS WITH RENAL PELVIS UPPER TRACT TRANSITIONAL CELL CARCINOMA HAVE SIGNIFICANTLY WORSE CANCER-SPECIFIC SURVIVAL THAN PATIENTS WITH URETERAL PRIMARIES (2009) (0)
- Editorial Comment. (2021) (0)
- MP38-20 SIMPLIFIED CLINICAL COMORBIDITY INDEX FOR PATIENTS CANDIDATE TO RADICAL CYSTECTOMY (2016) (0)
- Does an unexpected presence of non-organ disease at final pathology undermine cancer control in clinically T1N0M0 renal cell carcinoma patients who underwent partial nephrectomy? (2017) (0)
- Urological Survey Urological Oncology : Adrenal , Renal , Ureteral and Retroperitoneal Tumors Re : (2015) (0)
- Minimally invasive surgery for kidney cancer with venous thrombus: Oncological and functional outcomes from a multicentre serie (2018) (0)
- Letter to the EditorReply by the Authors (2009) (0)
- PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS (2023) (0)
- 301 When to perform preoperative bone scan for kidney cancer staging (2016) (0)
- Cancer Proceedings from the SIU B2B Uro-Oncology: GU Cancers Triad Virtual Meeting (2021) (0)
- WHEN TO PERFORM AN INTRAFASCIAL NERVE SPARING APPROACH WITHOUT COMPROMISING CANCER CONTROL. RESULTS OF A HIGH VOLUME SINGLE SURGEON SERIES (2009) (0)
- Pre-operative risk calculator of the probability of completing nephron-sparing surgery for kidney cancer: The key role of surgical experience and approach (2020) (0)
- 577 CAN UNILATERAL PROSTATE CANCER BE PREDICTED? IMPLICATIONS FOR FOCAL THERAPIES (2010) (0)
- MP58-17 IMPACT OF BENIGN HISTOLOGY ON PERIOPERATIVE COMPLICATION AND FUNCTIONAL OUTCOMES OF ROBOT ASSISTED PARTIAL NEPHRECTOMY (2023) (0)
- 1539 IS IIEF-EF A PROXY OF GENERAL MALE HEALTH STATUS? (2011) (0)
- 2022 WUOF/SIU International Consultation on Urological Diseases: Active Surveillance for Small Renal Masses (2022) (0)
- LONG‐TERM ASSESSMENT OF MORTALITY PATTERNS AFTER SURGICAL TREATMENT FOR NON‐METASTATIC KIDNEY CANCER: A COMPETING RISK ANALYSIS: MP55‐12 (2017) (0)
- PD46-05 A PROSPECTIVE, MULTICENTER EVALUATION OF PREDICTIVE FACTORS FOR POSITIVE SURGICAL MARGINS AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA: THE RECORD2 PROJECT (2019) (0)
- Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer. (2023) (0)
- First repeated biopsy represents the most informative predictor of progression-free survival at 3 years follow-up in patients included in an active surveillance protocol for low-risk prostate cancer (2017) (0)
- The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort (2022) (0)
- 1615: Sex Hormone Binding Globulin is a Significant Predictor of Extra Capsular Extension in Patients Undergoing Radical Retropubic Prostatectomy (2007) (0)
- MP48-07 PATTERNS AND PREDICTORS OF RESECTION TECHNIQUES DURING PARTIAL NEPHRECTOMY FOR T1 RENAL MASSES: RESULTS OF A MULTICENTRE PROSPECTIVE COHORT STUDY FROM THE SURFACE-INTERMEDIATE-BASE (SIB) MARGIN SCORE INTERNATIONAL CONSORTIUM (IDEAL PHASE 2B) (2018) (0)
- Combined assessment of long-term functional and oncologic outcomes after robot-assisted partial nephrectomy: The ROMe’s score (2020) (0)
- 563 IN HIGH-RISK PROSTATE CANCER, THE NUMBER OF LYMPH NODES REMOVED AT RADICAL PROSTATECTOMY DOES NOT AFFECT THE RISK OF CANCER RELATED DEATH OR DEATH FROM ANY CAUSE (2011) (0)
- The impact of ischemia on chronic kidney disease progression after robotic partial nephrectomy in patients over 75 years old: results of a multinstitutional collaborative series (ROSULA) (2020) (0)
- Unveil the interplay between baseline renal function, warm ischemia time and tumor complexity when assessing renal functional outcomes of on- vs. off-clamp robot-assisted partial nephrectomy (2023) (0)
- THE ABILITY OF THREE COMORBITY INDECES TO PREDICT POSTOSPERATIVE MORTALITY IN RENAL CELL CARCINOMA PATIENTS: THE IMPENDING NEED OF A NEW DISEASE‐SPECIFIC INDEX: MP55‐14 (2017) (0)
- A surgical nomogram for predicting the risk of positive surgical margins in patients treated with partial nephrectomy for renal cell carcinoma: The RECORd2 project (2019) (0)
- PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI‐CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES: MP55‐05 (2017) (0)
- MP69-01 CAN WE CONSIDER PATIENTS WITH LIMITED BIOPSY GLEASON SCORE 3+4 ELIGIBLE FOR ACTIVE SURVEILLANCE? (2014) (0)
- 570 The effect of preoperative cancer aggressiveness on learning curve among high volume surgeons performing radical retropubic prostatectomy: You never stop getting better in challenging cases (2012) (0)
- Gender disparities in kidney surgery: A real-life snapshot for a large prospective, multicenter observational study (the RECORd2 Project) (2022) (0)
- Feasibility of omitting outer (cortical) renorrhaphy during robotic partial nephrectomy - a multi-institutional analysis (2019) (0)
- The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain (2022) (0)
- Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities (2022) (0)
- 579 PREDICTION OF PERI-OPERATIVE MORTALITY AFTER TRANSURETHRAL RESECTION OF THE PROSTATE FOR BENIGN PROSTATIC HYPERPLASIA (2009) (0)
- 2224 HEAD-TO-HEAD COMPARISON OF PROSTATE HEALTH INDEX AND URINARY PCA3 ASSAY IN PREDICTING PROSTATE CANCER AT INITIAL OR REPEAT PROSTATE BIOPSY (2013) (0)
- MP69-15 OUTCOME OF RADICAL PROSTATECTOMY FOR MISCLASSIFIED ACTIVE SURVEILLANCE CANDIDATES (2014) (0)
- External validation and head-to-head comparison of all the prognostic models recommended by the European Association of Urology guidelines to predict oncologic outcomes in patients with renal cell carcinoma (2021) (0)
- 937 Prognostic value of tumour volume on disease progression of patients treated with radical prostatectomy for node positive prostate cancer (2015) (0)
- Renal function assessment during follow-up after surgical treatment for renal cell carcinoma (2019) (0)
- Management of atypical recurrence after treatment of localized renal cell carcinoma: Retrograde intrarenal surgery as an option (2023) (0)
- Active surveillance for very small renal masses: Analysis from an observational prospective trial (NCT03804320) (2023) (0)
- 1655 IMPACT OF TUMOR THROMBUS CONSISTENCY (SOLID VS FRIABLE) ON CANCER-SPECIFIC MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA AND VENOUS TUMOR THROMBUS (2011) (0)
- Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer? (2023) (0)
- PD29-12 COMPARISON OF ONCOLOGICAL OUTCOMES OF DISTAL URETERAL ≤PT2 UROTHELIAL CARCINOMA MANAGED BY NEPHROURETERECTOMY, SEGMENTAL URETERECTOMY OR ENDOSCOPIC SURGERY (2015) (0)
- Development of a nomogram to predict achievement of trifecta outcomes after robotic partial nephrectomy for cT1-2 renal tumors (2020) (0)
- PD43-10 TEMPORAL TRENDS AND UTILIZATION RATES OF LYMPH NODE DISSECTION IN PATIENTS WITH RENAL CELL CARCINOMA: IMPLICATIONS FOR ADJUVANT THERAPIES (2023) (0)
- Five-year trend of blood and urine cultures in a tertiary-referral urology center for hospitalized patients: a real-life study (2022) (0)
- 834 DEVELOPMENT AND INTERNAL VALIDATION OF A NOMOGRAM TO DETERMINE THE IMPACT OF THE BIOPSY SCHEME ON CANCER DETECTION IN MEN UNDERGOING AN INITIAL PROSTATE BIOPSY (2009) (0)
- Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma (2022) (0)
- 667 BLADDER CANCER STAGE DISTRIBUTION AT RADICAL CYSTECTOMY IN THE LAST TWO DECADES IN A POPULATION-BASED COHORT (2009) (0)
- Clinical and surgical predictors of acute kidney injury (AKI) after partial and radical nephrectomy. Results from a prospective multicenter observational study (the RECORD 2 project) (2019) (0)
- Reply by Authors. (2019) (0)
- MP57-17 PERIOPERATIVE OUTCOME AND ONCOLOGICAL FOLLOW UP IN A LARGE SERIES OF PATIENTS WITH RENAL CELL CARCINOMA INVADING SUPRADIAPHRAGMATIC VENA CAVA AND TREATED WITH NEPHRECTOMY AND CAVAL THROMBECTOMY WITH EXTRACORPOREAL CIRCULATION AND DEEP HYPOTHERMIC CIRCULATORY ARREST (2014) (0)
- MP78-13 PROGNOSTIC VALUE OF TUMOR VOLUME ON DISEASE PROGRESSION OF PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR NODE POSITIVE PROSTATE CANCER (2015) (0)
- The critical role of lymph node dissection in selecting high-risk non-metastatic renal cancer candidates for adjuvant therapy after nephrectomy (2019) (0)
- 722: Pathological Characteristics and Stage Migration of Patients with Prostate Cancer and Lymph Node Invasion Undergoing an Extended Pelvic Lymph Node Dissection at a Single Institution Over a 15 Year Period (2007) (0)
- PD12-06 RETROPERITONEAL VS. TRANSPERITONEAL ROBOTIC PARTIAL NEPHRECTOMY FOR POSTERO-LATERAL RENAL MASSES: AN INTERNATIONAL MULTICENTER ANALYSIS (2021) (0)
- 953 When to perform lymph node dissection in renal cell carcinoma patients: A novel approach to preoperatively assess the risk of lymph node invasion at surgery and nodal progression during follow up (2013) (0)
- Re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.06.002. (2019) (0)
- PS-06-002 Preoperative erectile dysfunction is a proxy of chronic kidney disease after surgery for renal cell carcinoma - a pilot study (2019) (0)
- MP36-16 THE ROLE OF HISTOLOGIC SUBTYPES IN FOLLOW-UP SCHEME OF POSTSURGICAL KIDNEY CANCER PATIENTS (2018) (0)
- Proposal for tripartite re-classification of T1 renal cell carcinoma into cT1a (very low risk), cT1b (low risk), and cT1c (intermediate risk) substages. (2019) (0)
- 947 A POPULATION-BASED STUDY OF PERIOPERATIVE MORTALITY AFTER RETROPERITONEAL LYMPHADENECTOMY FOR NON SEMINOMATOUS TESTICULAR GERM CELL TUMOURS: CLINICAL IMPLICATIONS FOR INFORMED CONSENT (2009) (0)
- Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study (2019) (0)
- Reply from Authors re: Michael W. Kattan. Classification and Regression Trees Versus Nomograms: A Bone Scan Positivity Example. Eur Urol 2010;57:559-60 (2010) (0)
- A prospective multicenter evaluation of predictive factors for positive surgical margins after partial nephrectomy for renal cell carcinoma: The RECORD2 project (2019) (0)
- PD46-09 HOW TO BALANCE THE RISK OF CANCER SPECIFIC MORTALITY AND OTHER CAUSE MORTALITY IN THE DECISION BETWEEN SURGERY OR OBSERVATION FOR PATIENTS WITH T1 KIDNEY CANCER (2016) (0)
- 1079 RADICAL PROSTATECTOMY AFTER PREVIOUS PROSTATE SURGERY: CLINICAL AND FUNCTIONAL OUTCOMES (2011) (0)
- AN ASSESSMENT OF THE MOST SIGNIFICANT DETERMINANTS OF THE NATURAL HISTORY OF UPPER TRACT TRANSITIONAL CELL CARCINOMA AFTER NEPHROURETERECTOMY: A MULTI-INSTITUTIONAL RECURSIVE PARTITIONING MODEL (2009) (0)
- MP48-15 EFFECTS OF SILODOSIN ON SEXUAL FUNCTION – REALISTIC PICTURE FROM THE EVERYDAY CLINICAL PRACTICE (2014) (0)
- Partial versus radical nephrectomy for the treatment of T1 renal tumors: A large contemporary matched-cohort study (RECORd2 Project) (2021) (0)
- The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy (2020) (0)
- MP47-18 SUSTAINABLE MULTIDISCIPLINARY TEAM REFERRAL FOR NON-METASTATIC RENAL CELL CARCINOMA: A SURVIVAL-BASED RECOMMENDATION (2022) (0)
- Proposal of a novel procedure-specific classification system for postoperative complications in patients undergoing robot-assisted radical prostatectomy (2018) (0)
- 795 PROGNOSTIC VALUE OF LYMPHNODE DISSECTION IN PATIENTS WITH MUSCLE-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE UPPER URINARY TRACT (2007) (0)
- RADICAL NEPHRECTOMY WITH OR WITHOUT LYMPH NODE DISSECTION FOR NON‐METASTATIC RENAL CELL CARCINOMA: A MULTI‐INSTITUTIONAL ANALYSIS: MP55‐16 (2017) (0)
- SP272KIDNEY ENDOWMENT PRESERVATION AND CLINICAL OUTCOME IN PATIENTS WITH RENAL CANCER: IS NEPHRON SPARING SURGERY ALWAYS SUPERIOR TO RADICAL NEPHRECTOMY IN TERM OF OTHER CAUSES MORTALITY? (2016) (0)
- Below the limit of 75 ml/min every unit of glomerular filtration rate counts: Assessing the role of renal function on cancer-related mortality in RCC (2018) (0)
- PD07-03 PROPOSAL FOR TRIPARTITE RECLASSIFICATION OF CT1 RENAL CELL CARCINOMA INTO CT1A (VERY LOW RISK), CT1B (LOW RISK), AND CT1C (INTERMEDIATE RISK) SUBSTAGES (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Umberto Capitanio?
Umberto Capitanio is affiliated with the following schools:
